Robert Peter Gale

Q: What Schools Are Affiliated With Robert Peter Gale

Robert Peter Gale is affiliated with the following schools: Thomas Jefferson University, New York Medical College, University at Buffalo, Medical College of Wisconsin, Weizmann Institute of Science, MD Anderson Cancer Center, Imperial College London, University of California, Los Angeles, Hobart and William Smith Colleges

Robert Peter Gale's AcademicInfluence.com Rankings

Robert Peter Gale

Biology

#721

World Rank

#1258

Historical Rank

#397

USA Rank

Microbiology

#49

World Rank

#66

Historical Rank

#26

USA Rank

biology Degrees

Robert Peter Gale

Philosophy

#2469

World Rank

#4210

Historical Rank

#875

USA Rank

Logic

#665

World Rank

#1159

Historical Rank

#242

USA Rank

philosophy Degrees

Download Badge

Biology
Philosophy

Why Is Robert Peter Gale Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Robert Peter Gale is an American physician and medical researcher. He is known for research in leukemia and other bone marrow disorders . Education Gale received his A.B. degree with honors in biology and chemistry from Hobart College in 1966 and his M.D. degree from the State University of New York at Buffalo in 1970 . His postgraduate medical training was at the University of California, Los Angeles from 1970 to 1973. In 1976 he received a Ph.D. in microbiology and immunology from the University of California at Los Angeles following doctoral work focusing on cancer immunology . His postdoctoral studies at UCLA were funded by the U.S. National Institutes of Health and the Leukemia Society of America, where he was the Bogart Fellow and Scholar.

(See a Problem?)

Robert Peter Gale's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Graft-versus-leukemia reactions after bone marrow transplantation. (1990) (2764)
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia (1985) (1587)
Chronic myeloid leukemia. (1992) (1200)
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. (2004) (1075)
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. (1988) (875)
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. (1990) (807)
T-cell depletion of HLA-identical transplants in leukemia. (1991) (787)
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. (1999) (632)
IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE (1997) (623)
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. (2004) (620)
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). (2000) (537)
Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. (1976) (536)
Risk factors for acute GVHD and survival after hematopoietic cell transplantation. (2012) (511)
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. (2002) (493)
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. (1997) (463)
Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene (1986) (451)
Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. (2010) (444)
Surface markers on leukemia and lymphoma cells: recent advances. (1982) (433)
A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. (1979) (416)
COVID-19 in persons with haematological cancers (2020) (361)
Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. (1986) (351)
Risk factors for acute graft‐versus‐host disease (1987) (342)
Infectious Complications of Human Bone Marrow Transplantation (1979) (340)
Transplant or chemotherapy in acute myelogenous leukaemia (1989) (336)
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. (1990) (326)
Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. (1993) (310)
Identical-Twin Bone Marrow Transplants for Leukemia (1994) (294)
Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. (1987) (289)
Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. (1989) (287)
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. (2015) (283)
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. (2002) (282)
Allogeneic bone marrow transplantation for low-grade lymphoma. (1998) (274)
Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. (2001) (274)
Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. (1993) (271)
Bone marrow transplantation for Fanconi anemia. (1995) (269)
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. (1997) (268)
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. (2007) (259)
Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial. (1986) (259)
SIMILAR OUTCOMES USING MYELOABLATIVE VERSUS REDUCED INTENSITY ALLOGENEIC TRANSPLANT PREPARATIVE REGIMENS FOR AML OR MDS (2011) (250)
Chronic lymphocytic leukemia: new insights into biology and therapy. (1990) (249)
Outcome of transplantation for myelofibrosis. (2010) (246)
Chronic graft versus host disease: a syndrome of disordered immunity. (1979) (244)
Hematologic Abnormalities in Fanconi Anemia: An International Fanconi Anemia Registry Study (1994) (237)
p53 in chronic myelogenous leukemia in acute phase. (1991) (235)
Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. (1992) (232)
Acute lymphoblastic leukemia: recent advances in biology and therapy. (1989) (228)
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors. (2016) (227)
Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis. (2013) (226)
HOW DOES BONE-MARROW TRANSPLANTATION CURE LEUKAEMIA? (1984) (225)
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. (2000) (222)
Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. (1989) (219)
HIGH REMISSION-INDUCTION RATE IN ACUTE MYELOID LEUKÆMIA (1977) (216)
Advances in the treatment of acute myelogenous leukemia. (1979) (212)
Cytomegalovirus immune plasma in bone marrow transplant recipients. (1982) (208)
Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. (1994) (207)
Gemtuzumab ozogamicin in acute myeloid leukemia (2017) (207)
A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia (1987) (205)
2013 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. (2013) (204)
Chronic myelogenous leukemia: biology and therapy. (1993) (203)
Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis (2020) (203)
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. (1996) (201)
An 8-kilobase abl RNA transcript in chronic myelogenous leukemia. (1984) (199)
Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. (1992) (197)
Cytomegalovirus infections associated with leukocyte transfusions. (1980) (194)
Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft‐versus‐leukaemia effect (1988) (194)
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. (1999) (194)
Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma. (2013) (190)
Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? (1993) (186)
Effect of methotrexate on relapse after bone-marrow transplantation for acute lymphoblastic leukaemia (1989) (185)
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission. (2010) (181)
Measurable residual disease testing in acute myeloid leukaemia (2017) (180)
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. (2008) (179)
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States. (2017) (177)
A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. (2006) (174)
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. (2010) (172)
Second HLA-identical sibling transplants for leukemia recurrence. (1992) (169)
Matched‐related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research (2007) (166)
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. (2010) (165)
Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. (1991) (164)
Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning. (2008) (157)
The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. (2009) (156)
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. (2000) (156)
Chronic lymphocytic leukemia. Recent advances in biology and treatment. (1985) (153)
Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis. (2011) (152)
ALTERED TRANSCRIPTION OF AN ONCOGENE IN CHRONIC MYELOID LEUKAEMIA (1984) (151)
Acute myelogenous leukemia: recent advances in therapy (1987) (151)
Outcome after allogeneic bone marrow transplant for leukemia in older adults. (1993) (151)
Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study. (2015) (149)
Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia. (1983) (149)
Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. (2005) (144)
Pneumococcal infections after human bone-marrow transplantation. (1979) (143)
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. (2013) (141)
Bone marrow transplantation for severe aplastic anemia: has outcome improved? (1997) (136)
Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors (2010) (135)
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia. (2008) (131)
2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. (2010) (130)
Intensive chemotherapy for acute myelogenous leukemia. (1981) (129)
Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality. (2014) (126)
Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia. (1981) (125)
GRAFT REJECTION AND GRAFT-VERSUS-HOST DISEASE: MIRROR IMAGES (1986) (124)
Bone marrow transplants for paroxysmal nocturnal haemoglobinuria (1999) (121)
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity? (2012) (121)
Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. (2000) (120)
ABO blood group barrier in allogeneic bone marrow transplantation revisited. (2005) (120)
Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research. (2014) (118)
Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group. (1998) (118)
Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia. (1981) (118)
HLA-matched sibling bone marrow transplantation for β-thalassemia major. (2011) (116)
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase (1993) (115)
CURE OF APLASTIC ANÆMIA IN PAROXYSMAL NOCTURNAL HÆMOGLOBINURIA BY MARROW TRANSFUSION FROM IDENTICAL TWIN: FAILURE OF PERIPHERAL-LEUCOCYTE TRANSFUSION TO CORRECT MARROW APLASIA (1979) (114)
USE OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR IN THE BRAZIL RADIATION ACCIDENT (1988) (114)
Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. (1995) (107)
FACTORS ASSOCIATED WITH INTERSTITIAL PNEUMONITIS AFTER BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIA (1982) (104)
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. (1993) (103)
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation. (2014) (103)
Hematological features of persons with COVID-19 (2020) (103)
Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma. (2009) (102)
Risk factors for death in 1859 subjects with COVID-19 (2020) (102)
Bone marrow transplantation in acute leukaemia. (1977) (102)
Salvage second hematopoietic cell transplantation in myeloma. (2013) (101)
Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry. (2004) (100)
Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome (1992) (100)
Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma. (2013) (100)
Pneumococcal vaccination of recipients of bone marrow transplants. (1983) (99)
Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide–total body irradiation versus busulphan–cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission (2002) (99)
Acute lymphoblastic leukemia in adults: recent progress, future directions. (1987) (98)
Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation. (1985) (97)
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of tyrosine kinase inhibitor and minimal residual disease (2013) (97)
Plasma cell leukemia. (1987) (96)
T cell depletion in bone marrow transplantation for leukemia: current results and future directions. (1988) (95)
Expression of the normal p53 gene induces differentiation of K562 cells. (1992) (94)
Hematopoietic recovery after 10-Gy acute total body radiation. (1994) (94)
bcr-abl RNA in patients with chronic myelogenous leukemia. (1987) (94)
Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation. Preliminary results of a controlled trial. (1984) (94)
What is hybrid acute leukemia? (1989) (94)
In vitro hepatitis B virus infection of human bone marrow cells. (1986) (93)
Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma. (2014) (93)
Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants. (1988) (93)
WHICH TREATMENT FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA IN SECOND REMISSION? (1987) (93)
Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortality. (1983) (92)
Alveolar macrophage dysfunction in human bone marrow transplant recipients. (1982) (92)
Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies. (1987) (88)
BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIA IN FIRST REMISSION (1982) (88)
Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia (2014) (87)
Recipient immune-competent T lymphocytes can survive intensive conditioning for bone marrow transplantation. (1986) (87)
IS THE INTERNATIONAL STAGING SYSTEM SUPERIOR TO THE DURIE SALMON STAGING SYSTEM? A COMPARISON IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANT (2009) (86)
Recent advances in the biology and treatment of acute lymphoblastic leukemia in adults. (1984) (86)
Decreased treatment failure in recipients of HLA‐identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses (2003) (85)
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. (2006) (85)
A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR. (2010) (84)
Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research. (2013) (83)
The early complications of bone marrow transplantation. (1984) (83)
Chronic myeloid leukemia stem cells (2019) (83)
Effects of footshock stress and morphine on natural killer lymphocytes in rats: studies of tolerance and cross-tolerance (1986) (82)
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. (1999) (82)
Acute myelogenous leukemia: recent advances in therapy. (1987) (82)
Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. (2010) (81)
Designed transfer of specific immune responses with bone marrow transplantation. (1986) (81)
Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. (2000) (81)
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. (2008) (81)
Prophylactic granulocyte transfusions during human bone marrow transplantation. (1980) (81)
Chemotherapy versus transplants for acute myelogenous leukemia in second remission. (1996) (80)
Controversies in the therapy of acute myelogenous leukemia. (1982) (79)
Results of Transplanting Bone Marrow from Genetically Identical Twins into Patients with Aplastic Anemia (1997) (78)
Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. (1988) (78)
Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s. (1992) (77)
Bone marrow transplantation from identical twins in the treatment of aplastic anaemia: implication for the pathogenesis of the disease (1984) (77)
Hematopoietic Cell Transplantation for Primary Plasma Cell Leukemia: Results from the Center for International Blood and Marrow Transplant Research (2011) (77)
High dose cytarabine: a review. (1988) (76)
ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR MYCOSIS FUNGOIDES AND SEZARY SYNDROME (2014) (76)
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. (2002) (75)
Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma. (2013) (75)
Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles County. (2000) (75)
Older patients with myeloma derive similar benefit from autologous transplantation. (2014) (74)
Suppression of natural killer cell activity by high-dose narcotic anesthesia in rats (1989) (74)
bcr genes and transcripts. (1988) (73)
Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age (2003) (73)
Regeneration of T cell subpopulations after bone marrow transplantation: cytomegalovirus infection and lymphoid subset imbalance. (1982) (73)
5th International Workshop on Chronic Lymphocytic Leukemia. (1992) (73)
Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis. (2011) (72)
What are RBC-transfusion-dependence and -independence? (2011) (72)
Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT (2018) (71)
Risk factors for interstitial pneumonia following bone marrow transplantation for severe aplastic anaemia (1989) (71)
Role of bone marrow transplantation in the treatment of hematologic malignancies and solid tumors: critical review of syngeneic, autologous, and allogeneic transplants. (1984) (70)
Improved survival after acute graft-versus-host disease diagnosis in the modern era (2017) (69)
Prior rituximab correlates with less acute graft‐versus‐host disease and better survival in B‐cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation (2009) (69)
BONE-MARROW TRANSPLANTATION IN HIGH-RISK ACUTE LYMPHOBLASTIC LEUKAEMIA IN FIRST AND SECOND REMISSION (1987) (68)
Paraplegia following intrathecal cytosine arabinoside (1979) (67)
High-dose combined-modality therapy and autologous bone marrow transplantation in resistant cancer. (1981) (67)
Infectious complications of bone marrow transplantation. (1984) (67)
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. (2019) (67)
Current use and trends in hematopoietic cell transplantation (2017) (67)
Autotransplants in chronic myelogenous leukaemia: strategies and results (1990) (66)
Graft‐versus‐Host Disease (1985) (65)
Immediate medical consequences of nuclear accidents. Lessons from Chernobyl. (1987) (65)
Improved survival following bone marrow transplantation for aplastic anaemia (1983) (65)
Biology of chronic lymphocytic leukemia. (1987) (65)
ABH Antigens and Bone Marrow Transplantation (1980) (64)
PROLONGED SURVIVAL IN ACUTE MYELOGENOUS LEUKAEMIA WITHOUT MAINTENANCE CHEMOTHERAPY (1984) (64)
Low dose cytosine arabinoside in myelodysplasia and acute myelogenous leukemia: a review. (1987) (63)
Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia. (2006) (63)
Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. (2011) (62)
Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? (1992) (62)
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant. (2008) (62)
Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation (2016) (60)
Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research. (2012) (60)
Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans (2014) (60)
Immunodeficiency following allogeneic bone marrow transplantation. (1978) (60)
DO ONCOGENES DETERMINE CLINICAL FEATURES IN CHRONIC MYELOID LEUKAEMIA? (1987) (60)
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia. (2017) (59)
Molecular biology of chronic myelogenous leukemia. (1988) (59)
Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients. (1988) (58)
Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia. (2013) (58)
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome. (2016) (57)
HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR. (2008) (57)
Autologous bone marrow transplants: Different indications in Europe and North America (1989) (57)
Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report (2017) (57)
Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. (2004) (56)
Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. (1992) (56)
Autotransplantation versus HLA‐matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research (2006) (56)
Nucleotide sequence analysis of human abl and bcr-abl cDNAs. (1989) (55)
The mystery of chronic lymphocytic leukemia (CLL): Why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology? (2015) (55)
THE MOLECULAR BIOLOGY OF CHRONIC MYELOGENOUS LEUKAEMIA (1985) (55)
Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase (1982) (55)
JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis (2021) (55)
Maintenance chemotherapy and cure of childhood acute lymphoblastic leukaemia (1991) (54)
Do androgens enhance the response to antithymocyte globulin in patients with aplastic anemia? A prospective randomized trial (1985) (53)
Allogeneic hematopoietic cell transplantation for metastatic breast cancer (2008) (53)
Progress in bone marrow transplantation (1987) (53)
Prevention of graft rejection following bone marrow transplantation (1981) (52)
Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors. (2015) (52)
Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease. (2016) (51)
Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma. (2015) (51)
The role of T-cells in preventing relapse in chronic myelogenous leukemia. (1987) (50)
Recent advances in the immunologic classification of leukemia. (1986) (49)
Cellular therapy for acute myeloid Leukemia - Current status and future prospects. (2019) (49)
The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen. (2015) (49)
Treatment of adults with acute myelogenous leukemia: prospective evaluation of high-dose cytarabine in consolidation chemotherapy and with bone marrow transplantation. (1987) (49)
Calreticulin mutations in Chinese with primary myelofibrosis (2014) (49)
SECOND TRANSPLANTS FOR MULTIPLE MYELOMA RELAPSING AFTER A PRIOR AUTOTRANSPLANT – REDUCED INTENSITY ALLOGENEIC VERSUS AUTOLOGOUS TRANSPLANTATION (2013) (49)
Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. (2011) (49)
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. (2009) (49)
Acute myelogenous leukemia: morphologic classification and response to therapy. (1979) (49)
1993 progress report from the International Bone Marrow Transplant Registry. Advisory Committee of the International Bone Marrow Transplant Registry. (1993) (48)
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis (2016) (48)
A Phase 2 Study of Luspatercept in Patients with Myelofibrosis-Associated Anemia (2019) (48)
A Prognostic Model Predicting Autologous Transplantation Outcomes in Children, Adolescents and Young Adults with Hodgkin Lymphoma (2015) (47)
JAK2V617F allele burden ⩾50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy (2016) (47)
Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse? (2020) (46)
Recent progress in chronic lymphocytic leukemia. International Workshop on chronic Lymphocytic Leukemia. (1994) (46)
MPN-associated myelofibrosis (MPN-MF). (2011) (46)
Development of the immune system in human fetal liver. (1987) (45)
Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse. (2009) (45)
Abnormalities of myeloid progenitor cells after "successful" bone marrow transplantation. (1985) (45)
Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research. (2013) (45)
CHEMOTHERAPY VERSUS TRANSPLANTATION IN ACUTE LEUKAEMIA (1989) (45)
GM-CSF incubation prior to treatment with cytarabine or doxorubicin enhances drug activity against AML cells in vitro: a model for leukemia chemotherapy. (1990) (45)
Autologous bone marrow transplantation in patients with cancer. (1980) (44)
Molecular abnormalities of bcr and c-abl in chronic myelogenous leukemia associated with a long chronic phase. (1988) (44)
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry. (2000) (44)
Hybrid acute leukemia. (1984) (44)
HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission. (1996) (44)
Immunoglobulin therapy in hematologic neoplasms and after hematopoietic cell transplantation. (2017) (43)
Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved. (2020) (43)
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group (2016) (43)
HYBRID ACUTE LEUKAEMIA (1987) (42)
Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia. (1984) (42)
Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s. (1991) (42)
Transplantation of ABH incompatible bone marrow: gravity sedimentation of donor marrow (1984) (41)
Hematopoiesis : long-term effects of chemotherapy and radiation (1989) (41)
Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report. (2017) (41)
Arrhythmias in the Setting of Hematopoietic Cell Transplants (2015) (41)
Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions. (2014) (41)
Bone marrow transplantation in man. (1975) (40)
Commentary: does immune suppression increase risk of developing acute myeloid leukemia? (2012) (40)
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR). (2008) (40)
Characterization of bcr gene products in hematopoietic cells. (1989) (40)
Are new conditioning regimens for transplants in acute myelogenous leukemia better? (1991) (39)
TET2, ASXL1 and EZH2 mutations in Chinese with myelodysplastic syndromes. (2013) (39)
Chronic GVHD: Where are we? Where do we want to be? Will immunomodulatory drugs help? (2013) (39)
Blood stem cell transplants come of age. (1992) (39)
What does total body irradiation do in bone marrow transplants for leukemia? (1991) (39)
New drug approvals in acute myeloid leukemia: what’s the best end point? (2015) (39)
AUTOTRANSPLANTS IN LEUKAEMIA (1989) (39)
Young age and high cost are associated with future preference for stopping tyrosine kinase inhibitor therapy in Chinese with chronic myeloid leukemia (2016) (39)
Therapy of acute myelogenous leukemia. (1992) (39)
ABO blood group system and bone marrow transplantation. (1977) (38)
Graft failure and leukemia relapse following T lymphocyte-depleted bone marrow transplants: effect of intensification of immunosuppressive conditioning. (1987) (38)
Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. (2014) (38)
A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome (2018) (38)
Thymus-dependent lymphocytes in human bone marrow. (1975) (38)
Amsacrine: a review. (1986) (37)
Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: A Center for International Blood and Marrow Transplant Research Analysis (2017) (37)
Blood-derived haematopoietic cell transplants: blood to blood? (1991) (37)
Insights into the expression of ABH and Lewis antigens through human bone marrow transplantation. (1981) (37)
What does MRD in leukemia really mean? (2014) (37)
Rapid progress in chronic myelogenous leukemia. (1988) (37)
Progress in acute myelogenous leukemia. (1984) (36)
Autotransplantation after in vitro immunotherapy of lymphoblastic leukemia. (1979) (36)
Latin America: the next region for haematopoietic transplant progress (2017) (36)
Contamination of marihuana cigarettes with pathogenic bacteria--possible source of infection in cancer patients. (1982) (36)
Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant (2020) (36)
GVHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes (2016) (36)
CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia (2014) (36)
Etoposide in leukemia, lymphoma and bone marrow transplantation. (1989) (36)
PROGNOSTIC FACTORS FOR OUTCOMES IN ALLOGENEIC TRANSPLANTATION FOR ADVANCED PHASES OF CHRONIC MYELOID LEUKEMIA IN THE IMATINIB ERA: A CIBMTR ANALYSIS (2011) (36)
Molecular techniques for the personalised management of patients with chronic myeloid leukaemia (2017) (36)
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia (2016) (36)
A Decision Analysis of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients with De-Novo Myelodysplastic Syndrome (MDS): Early Transplantation Offers Survival Benefit in Higher-Risk MDS (2011) (35)
Unique features of primary myelofibrosis in Chinese. (2012) (35)
Graft versus leukemia (1992) (35)
ALTERNATIVE DONORS EXTEND TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA WHO LACK AN HLA MATCHED DONOR (2014) (35)
Allogeneic bone marrow transplantation for leukemia. (1994) (35)
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. (2018) (34)
Allogeneic hematopoietic cell transplant for prolymphocytic leukemia. (2010) (34)
Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma. (2015) (34)
Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age. (2017) (34)
Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission (2020) (34)
Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. (2014) (34)
Sex differences in the incidence of chronic myeloid leukemia (2014) (33)
E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy (2017) (33)
New cancers after autotransplantations for multiple myeloma. (2015) (33)
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation (2015) (33)
Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma (2015) (33)
Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies. (2016) (33)
Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring sideroblasts. (2012) (33)
Lymphocyte dysfunction in chronic graft-versus-host disease. (1981) (32)
Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia (2015) (32)
Fatal veno-occlusive disease of the liver following high-dose 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and autologous bone marrow transplantation. (1981) (32)
Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors (2019) (32)
Do androgens enhance the response to antithymocyte globulin in patients with aplastic anemia? A prospective randomized trial. (1985) (32)
Post-transplant cyclophosphamide use in matched HLA donors: a review of literature and future application (2019) (32)
Cancer care in the Palestinian territories. (2018) (31)
Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia (2016) (31)
Therapy of acute myelogenous leukemia. (1992) (31)
MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma (2017) (31)
Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia. (2016) (31)
Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody. (1984) (30)
Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study. (2010) (30)
Acute leukemia: biology and treatment. (1979) (30)
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation. (2019) (30)
Fetal liver transplantation (2011) (30)
Comparison of twin and autologous transplants for multiple myeloma. (2008) (29)
Multiple molecular abnormalities in Ph1 chromosome positive acute lymphoblastic leukaemia (1987) (29)
Collective biodosimetry as a dosimetric "gold standard": a study of three radiation accidents. (1997) (29)
Bone marrow transplantation--1994: a report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. (1994) (29)
Haematopoietic cell transplants in Latin America (2016) (29)
Adult acute leukemia. (1994) (29)
BCR/ABL and leukemia. (1996) (29)
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation. (2019) (28)
Functional and genetic aberrations of in vitro-cultured marrow-derived mesenchymal stromal cells of patients with classical Philadelphia-negative myeloproliferative neoplasms (2014) (28)
Freezing the graft is not necessary for autotransplants for plasma cell myeloma and lymphomas (2018) (28)
HOW CAN WE CURE LEUKAEMIA? (1989) (28)
ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE (2013) (27)
Leukemia of T-helper lymphocytes: clinical and functional features. (1981) (27)
Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis. (2018) (27)
Should persons with acute myeloid leukemia have a transplant in first remission? (2014) (27)
Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry--North America. (1994) (27)
Autologous haematopoietic cell transplantation for non‐Hodgkin lymphoma with secondary CNS involvement (2013) (27)
How good are we at predicting the fate of someone with acute myeloid leukaemia? (2017) (27)
Potential utilization of a national HLA-typed donor pool for bone marrow transplantation. (1986) (27)
Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia (2016) (27)
Acute lymphoblastic leukemia with giant intracytoplasmic inclusions. (1980) (27)
Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort. (2015) (27)
Bone marrow transplantation in chronic myelogenous leukemia. (1992) (26)
T-cell depletion in allogeneic bone marrow transplantation: progress and problems. (1989) (26)
Prevention of graft rejection following bone marrow transplantation. (1981) (26)
Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee. (1995) (26)
Radiation accidents and nuclear energy: medical consequences and therapy. (1988) (26)
Bone marrow transplantation for Diamond-Blackfan anemia. (1995) (26)
B cell acute lymphoblastic leukemia (ALL) in donor cells following bone marrow transplantation for T cell ALL. (1988) (25)
Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT. (2020) (25)
Multiple myeloma and chronic lymphocytic leukemia: parallels and contrasts. (1992) (25)
VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder (2021) (25)
Genetically identical twin transplantation for chronic lymphocytic leukemia (2007) (25)
Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19) (2021) (25)
CML-T1: a cell line derived from T-lymphocyte acute phase of chronic myelogenous leukemia. (1989) (25)
Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease. (2017) (25)
Ph-chromosome positive acute leukemias and acute phase CML: one or two diseases? Two. (1990) (25)
Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantation (2019) (25)
Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response (2018) (25)
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis. (2016) (25)
Oncogenes and leukemia. (1990) (25)
Case problems in bone marrow transplantation. I. Graft failure in aplastic anemia: its biology and treatment. (1984) (24)
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation. (2008) (24)
High-dose cytarabine in consolidation chemotherapy or with bone marrow transplantation for patients with acute leukemia: preliminary results. (1985) (24)
Use of conditioned media in cell culture can mask cytogenetic abnormalities in acute leukemia. (1990) (24)
Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure. (2012) (24)
Antineoplastic chemotherapy myelosuppression: mechanisms and new approaches. (1985) (24)
Modeling minimal residual disease (MRD)-testing. (2003) (24)
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia. (2019) (24)
The role of hematopoietic growth factors in nuclear and radiation accidents. (1990) (24)
Isolation, cryopreservation, and autotransplantation of human stem cells. (1979) (24)
NK-/T-cell lymphomas (2021) (23)
BONE-MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKAEMIA (1983) (23)
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma. (2017) (23)
JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasms (2013) (23)
The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues (2011) (23)
Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine. (2018) (23)
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission. (1998) (23)
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide. (2019) (23)
Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry. (1990) (23)
Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants? (2009) (23)
Bone marrow autotransplantation. (1989) (22)
5'-Triphosphate siRNA targeting MDR1 reverses multi-drug resistance and activates RIG-I-induced immune-stimulatory and apoptotic effects against human myeloid leukaemia cells. (2017) (22)
Evidence- and consensus-based recommendations for phlebotomy in polycythemia vera (2018) (22)
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia (2021) (22)
Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis. (2004) (22)
Do persons with chronic myeloid leukaemia have normal or near normal survival? (2019) (22)
Cancer after bone marrow transplantation (1992) (22)
Long survival in acute myelogenous leukaemia: an international collaborative study. (1981) (22)
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia. (2018) (22)
Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era (2020) (21)
Posttransfusion hepatitis in acute myelogenous leukemia. Effect on survival. (1980) (21)
Delphi‐panel analysis of appropriateness of high‐dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer (2000) (21)
Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research. (2013) (21)
No increased mortality from donor or recipient hepatitis B‐ and/or hepatitis C‐positive serostatus after related‐donor allogeneic hematopoietic cell transplantation (2012) (20)
Interleukin-22 accelerates thymus regeneration via Stat3/Mcl-1 and decreases chronic graft-versus-host disease in mice after allotransplants. (2019) (20)
Use of molecularly-cloned haematopoietic growth factors in persons exposed to acute high-dose, high-dose rate whole-body ionizing radiations. (2020) (20)
Does ruxolitinib improve survival of persons with MPN-associated myelofibrosis? Should it? (2014) (20)
Analysis of bone marrow transplantation data in man. (1986) (20)
Discrete clusters of hematopoietic cells in the marrow cavity of man after bone marrow transplantation. (1977) (20)
Oncogenes in chronic lymphocytic leukemia. (1988) (20)
Current status of bone marrow transplantation in humans: report from the International Bone Marrow Transplant Registry. (1988) (20)
Blood stem cell transplants (1994) (20)
Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. (2006) (20)
Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries. (2020) (20)
Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia. (2009) (19)
Progress in bone marrow transplantation in man (1982) (19)
Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia (2020) (19)
Higher out-of-pocket expenses for tyrosine kinase-inhibitor therapy is associated with worse health-related quality-of-life in persons with chronic myeloid leukemia (2017) (19)
Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR. (2012) (19)
Use of the Functional Assessment of Cancer Therapy--anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia. (2014) (19)
THE ROLE OF BONE-MARROW TRANSPLANTS AFTER NUCLEAR ACCIDENTS (1988) (19)
Chronic leukemias: oncogenes, chromosomes, and advances in therapy. (1986) (19)
Short stature, Fanconi's anaemia, and risk of leukaemia after growth hormone therapy (1994) (18)
Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma. (2017) (18)
Autotransplants: now and in the future. (1991) (18)
BCL11A expression in acute myeloid leukemia. (2016) (18)
Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival. (2019) (18)
Increasing Use of Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients Age 70 Years and Older: A CIBMTR Study of Trends and Outcomes (2016) (18)
Prognostic impact of Epstein-Barr virus (EBV)-DNA copy number at diagnosis in chronic lymphocytic leukemia (2015) (18)
Number of HLA mismatched eplets is not associated with major outcomes in haploidentical transplantation with post-transplantation cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study. (2021) (18)
Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics (2017) (18)
Molecular monitoring of tyrosine kinase inhibitor therapy of chronic myeloid leukemia in China (2016) (18)
Do chromosome abnormalities determine the type of acute leukemia that develops in CML? (1990) (18)
Bone Marrow Therapies for Chronic Heart Disease (2015) (18)
Fetal liver transplantation in aplastic anemia and leukemia. (1987) (18)
Is there expert consensus on expert consensus? (2018) (17)
Prospects for achieving treatment‐free remission in chronic myeloid leukaemia (2020) (17)
Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA (2017) (17)
Is there immune surveillance against chronic myeloid leukaemia? Possibly, but not much. (2017) (17)
Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia (2017) (17)
PRETRANSPLANT LYMPHOCYTOTOXINS AND BONE-MARROW GRAFT REJECTION (1978) (17)
A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes (2016) (17)
Monosomal karyotype is an independent predictor of survival in patients with higher‐risk myelodysplastic syndrome (2014) (17)
Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes. (2015) (17)
Prophylaxis of infection in bone marrow transplants. (1988) (17)
Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma. (2019) (17)
Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations. (2015) (17)
Generic immunosuppressants in hematopoietic cell transplantation. (2011) (17)
Concise review: Bone marrow autotransplants for liver disease? (2013) (17)
BCR-ABL rearrangements in children with Philadelphia chromosome-positive chronic myelogenous leukemia. (1991) (17)
Critical appraisal of the role of ruxolitinib in myeloproliferative neoplasm-associated myelofibrosis (2015) (16)
Bone marrow transplantation between a histocompatible parent and child for acute leukemia. (1978) (16)
Autologous GVHD? (2014) (16)
Imatinib results in better outcomes than HLA-identical sibling transplants in young persons with newly diagnosed chronic-phase chronic myelogenous leukemia (2013) (16)
Total Gastrectomy: Mortality and Survival (1958) (16)
Comparison of high doses of total body irradiation in myeloablative conditioning prior to hematopoietic cell transplantation. (2019) (16)
Therapy-related AML: a slip of the lip can sink a ship. (2014) (16)
Outcomes following autologous hematopoietic stem cell transplant for patients with relapsed Wilms’ Tumor: A CIBMTR retrospective analysis (2017) (16)
Molecular and clinical features of myeloid neoplasms with somatic DDX41 mutations (2020) (16)
Immunoglobulin synthesis following allogeneic bone marrow transplantation in man. Conversion to donor allotype. (1979) (16)
Morphologic aspects of bone marrow transplantation in patients with aplastic anemia. (1978) (16)
Initiation and progression of chronic myelogenous leukemia. (1992) (16)
Chronic myelogenous leukemia--the unfolding saga. (1990) (16)
Myeloid Growth Factors in Cancer Treatment (1993) (15)
Precision medicine in acute myeloid leukemia: Hope, hype or both? (2016) (15)
Why is there so much therapy-related AML and MDS and so little therapy-related CML? (2014) (15)
Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia. (2015) (15)
Acute myeloid leukaemia: recent advances in therapy. (1986) (15)
Does auto-immunity contribute to anemia in myeloproliferative neoplasms (MPN)-associated myelofibrosis? (2010) (15)
Outcomes of human leukocyte antigen-matched sibling donor hematopoietic cell transplantation in chronic lymphocytic leukemia: myeloablative versus reduced-intensity conditioning regimens. (2014) (15)
Autoreactivity between lymphocytes and thymus cells in myasthenia gravis. (1978) (15)
Relationship between clonality and transformation in acute leukemia. (1991) (15)
Granulocytes in human disease. (1974) (14)
BCL11A expression in acute phase chronic myeloid leukemia. (2016) (14)
Acute myelogenous leukemia: current status of therapy in adults. (1984) (14)
Direct adjusted survival and cumulative incidence curves for observational studies (2019) (14)
Acute myeloid leukemia therapy and the chosen people (2017) (14)
IBMTR analysis of bone marrow transplants in acute leukaemia. Advisory Committee of the International Bone Marrow Transplant Registry (IBMTR). (1989) (14)
Providing personalized prognostic information for adult leukemia survivors. (2013) (14)
High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcoma. (2010) (14)
Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia? (2014) (14)
Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection (2020) (14)
Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT (2019) (14)
Bone marrow transplantation in acute leukemia using intensive chemoradiotherapy (SCARI--UCLA). (1976) (14)
Reduced frequency of circulating CD4+CD25brightCD127lowFOXP3+ regulatory T cells in primary myelofibrosis. (2016) (14)
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs. (2017) (14)
Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia (2014) (14)
An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy (2020) (14)
Patients’ and hematologists’ concerns regarding tyrosine kinase-inhibitor therapy in chronic myeloid leukemia (2018) (13)
Myeloproliferative (MPN) Symptom Burden Response Thresholds: Assessment Of MPN-SAF TSS Quartiles As Potential Markers Of Symptom Response (2013) (13)
Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysis. (2007) (13)
Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia (2016) (13)
Ionizing radiation exposures in treatments of solid neoplasms are not associated with subsequent increased risks of chronic lymphocytic leukemia. (2016) (13)
Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time? (2021) (13)
Progress in allogeneic bone marrow transplantation for acute lymphoblastic leukemia in the 1980's: a report from the IBMTR. The International Bone Marrow Transplant Registry. (1992) (13)
Calculating Risk: Radiation and Chernobyl. (1987) (13)
Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. (2020) (13)
Long-term bone marrow culture in persons with Fanconi anemia and bone marrow failure. (1994) (13)
Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia. (2013) (13)
Phase-1 Study of PF-114 Mesylate in CML Failing Prior Tyrosine Kinase-Inhibitor Therapy (2018) (13)
Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European S (2019) (13)
Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study (2019) (13)
Ethnic and geographic diversity of chronic lymphocytic leukaemia (2020) (12)
AUTOTRANSPLANTS IN ACUTE LEUKAEMIA (1991) (12)
Is there an epidemic of chronic lymphocytic leukaemia (CLL) in China? (2018) (12)
The role of bone marrow transplantation following nuclear accidents. (1987) (12)
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation. (2019) (12)
PF-114: A 4th Generation Tyrosine Kinase-Inhibitor for Chronic Phase Chronic Myeloid Leukaemia Including BCRABL1T315I (2019) (12)
A prognostic survival model based on metabolism-related gene expression in plasma cell myeloma (2021) (12)
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis (2017) (12)
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors. (2022) (12)
AGE OF ONSET AND TYPE OF LEUKAEMIA (1989) (12)
Acute myelogenous leukemia following radiation therapy and chemotherapy for osteogenic sarcoma. (1984) (12)
Variables associated with patient-reported outcomes in persons with chronic myeloid leukemia receiving tyrosine kinase-inhibitor therapy (2017) (12)
What is the P-value anyway? (2016) (12)
Serum inhibitors of in vitro hematopoiesis and graft outcome in bone marrow transplantation for aplastic anemia. (1980) (12)
Is there an effective therapy for chronic graft-versus-host disease? (1993) (12)
Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant (2019) (12)
Effect of acute and chronic graft-versus-host disease on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma (2011) (12)
Use of intravenous immune globulin in patients receiving bone marrow transplants (1982) (12)
Methotrexate therapy of T-cell large granular lymphocytic leukemia impact of STAT3 mutation (2016) (12)
Immunologic classification of lymphoma and lymphoid leukemia. (1987) (12)
Are mild/moderate acquired idiopathic aplastic anaemia and low-risk myelodysplastic syndrome one or two diseases or both and how should it/they be treated? (2016) (12)
Analysis of BCR/ABL abnormalities in mRNA from 20-year-old paraffin-embedded tissue for BCR/ABL rearrangement by polymerase chain reaction. (1993) (12)
Bone Marrow Transplantation for Acute Myelogenous Leukemia (1997) (12)
Use of hematopoietic growth factors in radiation accidents. (1990) (12)
Therapy of posttransplant poor graft function with eltrombopag (2020) (12)
Causal inference in randomized clinical trials (2019) (12)
Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant? (2020) (12)
Perspective: SARS-CoV-2, COVID-19 and Haematologists (2020) (11)
Are some cases of acute leukemia with t(8;21) hybrid leukemias? (1990) (11)
New drugs in AML: uses and abuses (2018) (11)
Maintenance of human haematopoietic stem and progenitor cells in vitro using a chemical cocktail (2018) (11)
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation. (2015) (11)
Assessment of Minimal Residual Disease in Standard-Risk AML. (2016) (11)
Staging and therapy of chronic lymphocytic leukemia. (1987) (11)
Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants. (2018) (11)
A randomized phase-2 trial of pomalidomide in subjects failing prior therapy of chronic graft-versus-host disease. (2020) (11)
Bone Marrow Transplantation: Its Biology and Role as Treatment for Acute and Chronic Leukemias (1987) (11)
Is there a role for autotransplants in acute leukemia? (1989) (11)
Fetal liver transplants. (1992) (11)
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase. (1999) (11)
TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia. (2016) (11)
Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS. (2020) (11)
Medical and policy considerations for nuclear and radiation accidents, incidents and terrorism (2017) (11)
G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19? (2020) (11)
The myelodysplastic syndromes (2007) (11)
Conquest of COVID‐19. Publish it to death? (2020) (11)
Is the Sokal or EUTOS long-term survival (ELTS) score a better predictor of responses and outcomes in persons with chronic myeloid leukemia receiving tyrosine-kinase inhibitors? (2021) (11)
Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late Effects. (1992) (10)
Safety and tolerance of recombinant leukocyte A interferon in bone marrow transplant recipients (1983) (10)
How do transplants cure chronic myelogenous leukemia? (1992) (10)
Can we prevent or treat graft-versus-host disease with cellular-therapy? (2020) (10)
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study (2020) (10)
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Myelodysplastic Syndromes Patients. (2020) (10)
Bone marrow transplants for chronic lymphocytic leukaemia. (1992) (10)
Outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation (2020) (10)
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission. (1999) (10)
High incidence of MYD88 and KMT2D mutations in Chinese with chronic lymphocytic leukemia (2021) (10)
Engraftment syndrome, the Emperor’s new clothes and the artist formerly known as prince (2015) (10)
What is the (p-) value of the P-value? (2016) (10)
Myasthenia gravis and polymyositis in a dog following fetal hematopoietic cell transplantation. (1986) (10)
Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis (2017) (10)
Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between Groups. (2018) (10)
Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation (2016) (10)
Emergency response to radiological and nuclear accidents and incidents (2019) (10)
Predicting the outcome of patients with chronic lymphocytic leukemia: Progress and uncertainty (2019) (10)
The Effect of Endotoxin on Circulating Lymphocytes in Normal Man (1977) (10)
Leukemia: stem cells, preleukemia and cure. (1992) (10)
Hypothesis: how do JAK2-inhibitors work in myelofibrosis. (2009) (10)
Is there a T-cell form of chronic lymphocytic leukemia? (1992) (10)
Medical response to radiation and nuclear accidents: lessons for the future. (1988) (9)
Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms. (2018) (9)
The big freeze may be over: a contracting universe for cryopreservation? (2018) (9)
Chinese and Europeans with acute myeloid leukemia have discordant mutation topographies. (2018) (9)
ABSENCE OF SPECIFIC MIXED LEUKOCYTE CULTURE REACTIVITY DURING GRAFT‐VERSUS‐HOST DISEASE AND FOLLOWING BONE MARROW TRANSPLANT REJECTION (1976) (9)
Being certain even when you’re wrong: heuristics and thin slicing in haematopoietic cell transplantation (2020) (9)
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia. (2019) (9)
Prognostic value of whole-body SUVmax of nodal and extra-nodal lesions detected by 18F-FDG PET/CT in extra-nodal NK/T-cell lymphoma (2016) (9)
If the unlikely becomes likely: Medical response to nuclear accidents (2011) (9)
Autotransplants in leukemia: current state, future progress. (1991) (9)
Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America. (1995) (9)
Synopsis and prospectives on fetal liver transplantation. (1987) (9)
Significance of HLA and non-HLA antigens in bone marrow transplantation. (1978) (9)
Who is the best alternative allotransplant donor? (2015) (9)
Is G-CSF Dangerous in COVID-19: Why Not Use GM-CSF? (2020) (9)
Serum Ferritin Is an Independent Prognostic Factor in Chinese with Myelodysplastic Syndromes Classified as IPSS Intermediate-1 (2013) (9)
Final Warning: The Legacy of Chernobyl (1988) (9)
The regulation of hematopoiesis following bone marrow transplantation. (1987) (9)
Therapy of older persons with acute myeloid leukaemia. (2017) (9)
Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades. (2019) (9)
What determines who develops graft-versus-host disease: the graft or the host (or both)? (1992) (9)
Medical response to nuclear and radiation accidents. (1991) (9)
Phase-1/-2 study of pomalidomide in chronic GvHD (2016) (9)
The role of bone marrow transplantation in adult acute lymphocytic leukemia. (1993) (9)
Graft-vs-leukemia following bone marrow transplantation: a model of immunotherapy in man. (1987) (9)
Pomalidomide Therapy in Anemic Patients with Myelofibrosis: Results from a Phase-2 Randomized Multicenter Study (2008) (9)
Detection of non-HLA antibodies in bone marrow transplant recipients. (1978) (8)
Measureable residual disease (MRD): much ado about nothing? (2015) (8)
Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation (2017) (8)
Early and late graft-failure after transplants (2016) (8)
Reduced CXCR4-expression on CD34-positive blood cells predicts outcomes of persons with primary myelofibrosis (2020) (8)
Variables associated with patient-reported symptoms in persons with chronic phase chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy (2019) (8)
Therapy-free remission in chronic myeloid leukemia: possible mechanism (2018) (8)
DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia (2020) (8)
Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome? (2020) (8)
Insomnia, Quality Of Life and MPN Symptom Burden: An Analysis By The MPN Quality Of Life International Study Group (MPN-QOL ISG) (2013) (8)
Why chronic myeloid leukaemia cannot be cured by tyrosine kinase-inhibitors (2021) (8)
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis (2021) (8)
A rapid, highly accurate method for quantifying CALR mutant allele burden in persons with myeloproliferative neoplasms (2015) (8)
Current status of allogeneic bone marrow transplantation in leukemia: a report from the International Bone Marrow Transplant Registry. (1987) (8)
Treating Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors (2013) (8)
Further experience with infections in bone marrow transplant recipients. (1978) (8)
The different prognostic impact of type‐1 or type‐1 like and type‐2 or type‐2 like CALR mutations in patients with primary myelofibrosis (2016) (8)
Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation. (2021) (8)
Trisomy 12 in Burkitt-like lymphoma associated with acquired immunodeficiency syndrome. (1987) (8)
Is lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma? (2019) (8)
Radiation accidents: primum non nocere. (1993) (8)
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report (2019) (8)
Is cancer latency an outdated concept? Lessons from chronic myeloid leukemia (2020) (8)
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma. (1998) (8)
Latin America: the next region for haematopoietic transplant progress (2017) (8)
First use of myeloid colony-stimulating factors in humans (2013) (8)
Chemotherapy versus transplantation: I. Acute myelogenous leukemia. (1989) (7)
Autotransplantation for leukemia and solid tumors. (1978) (7)
Transplants of blood-derived hematopoietic cells. (1990) (7)
Current status of allogeneic and autologous blood and marrow transplantation: Report from the IBMTR and ABMTR — North America (1996) (7)
What's new in blood progenitor cell autotransplants? (1994) (7)
Is transplantation in first remission AML more effective than in advanced leukemia? (1989) (7)
Fetal liver transplantation : current concepts and future directions : proceedings of the First International Symposium on Fetal Liver Transplantation, Pesaro, Italy, September, 1979 (1980) (7)
Bone marrow transplantation for thalassaemia--a preliminary report from the International Bone Marrow Transplant Registry. (1989) (7)
Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure. (2015) (7)
Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation (2021) (7)
‘A rose by any other name would smell as sweet’, or would it? (2013) (7)
HLA-identical sibling bone marrow transplants for acute lymphoblastic leukemia (1995) (7)
A predictive score for progression of COVID-19 in hospitalized persons: a cohort study (2021) (7)
Oncogenes and human leukemias. (1988) (7)
Detecting minimal residual leukemia. (1991) (7)
New and evolving concepts in leukemia. (1988) (7)
Prognostic impact of red blood cell distribution width in myelodysplastic syndromes (2019) (7)
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myeloma. (1999) (7)
Immunity to human haematopoietic stem cells (1979) (7)
Sustained recovery of hematopoiesis and immunity following transplantation of fetal liver cells in dogs. (1987) (7)
Graft versus leukemia in humans. (1995) (6)
Inferior Outcomes with Cyclosporine and Mycophenolate mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation. (2019) (6)
Microtransplantation for Acute Myeloid Leukemia: A Systematic Review. (2020) (6)
Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase (2020) (6)
Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide (2020) (6)
New strategies for T cell depletion. (1990) (6)
Hybrid leukemia and the 5q-abnormality. (1991) (6)
Do different therapies of AML produce different outcomes? (1990) (6)
Relationship between leukemia antigens and stimulation in mixed leukocyte culture. (1977) (6)
High incidence of conservative RAS mutations in acute myeloid leukemia. (1994) (6)
Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation. (2017) (6)
Mélange intéressante: COVID-19, autologous transplants and multiple sclerosis (2020) (6)
Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation. (2019) (6)
How best to analyse new strategies in bone marrow transplantation. (1990) (6)
Erratum: Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants? (Bone Marrow Transplantation (2009) vol. 43 (435-446) 10.1038/bmt.2008.447) (2009) (6)
Bone marrow transplantation in acute lymphoblastic leukemia. (1990) (6)
What Does Chronic Myeloid Leukaemia Tell Us About Other Leukaemias? (2019) (6)
Determine safety of outpatient chemotherapy and autotransplants using refrigerated, non‐frozen grafts in persons with multiple sclerosis (2019) (6)
Acute transformation of chronic lymphocytic leukemia. (1984) (6)
The Myelofibrosis Symptom Burden (MF-SB): An International Phenotypic Cluster Analysis of 329 Patients (2012) (6)
Sexuality Challenges, Intimacy, and MPN Symptom Burden: An Analysis By The MPN Quality Of Life International Study Group (MPN-QOL ISG) (2013) (6)
Refining AML outcome prediction (2018) (6)
Is Having Clonal Cytogenetic Abnormalities the Same as Having Leukaemia? (2015) (6)
Ureidopenicillins, aztreonam, and thienamycin: efficacy as single-drug therapy of severe infections and potential as components of combined therapy. (1986) (6)
Low frequency of mutations in Chinese with acute myeloid leukemia: Different disease or different aetiology? (2015) (6)
Prognostic impact of splenomegaly on survival of Chinese with primary myelofibrosis. (2014) (6)
The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia. (1988) (6)
RBC-transfusion guidelines update. (2012) (6)
Comparison of chemotherapy and bone marrow transplants using two independent clinical databases. (1994) (6)
Advances and controversies in thalassemia therapy. Bone marrow transplantation and other approaches. Proceedings of an International Symposium on Bone Marrow Transplantation and Related Problems. Urbino, Italy, September 22-25, 1988. (1989) (6)
Does ruxolitinib really prolong survival in individuals with myelofibrosis? The never-ending story (2022) (6)
Approaches to leukemic relapse following bone marrow transplantation. (1978) (6)
Abnormal T-lymphocyte colonies (CFU-TL) following bone marrow transplantation. (1986) (6)
Intravenous immunoglobulin in bone marrow transplantation (1991) (6)
Plasma sIL-2Rα levels are associated with disease progression in myelofibrosis with JAK2V617F but not CALR mutation. (2020) (6)
Histiocytic lymphoma following resolution of sarcoidosis. (1981) (6)
How important is hepatitis C virus (HCV)-infection in persons with acute leukemia? (1997) (6)
Markov model of CLL transplants (2012) (5)
Factors influencing the risk of acute and chronic graft-versus-host disease in humans: a preliminary report from the IBMTR. (1989) (5)
Successful bone marrow transplantation against mixed lymphocyte culture barrier. (1976) (5)
HLA-matched sibling bone marrow transplantation for (cid:1) -thalassemia major (2011) (5)
Treatment of radiation victims in Brazil. (1988) (5)
Managing myeloproliferative neoplasms evidence based on the ELN treatment recommendations 2018 (2018) (5)
Role of molecularly-cloned hematopoietic growth factors after acute high-dose radiation exposures (2021) (5)
Correcting 2 more myths regarding transplants for AML in second remission. (2014) (5)
Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. (1993) (5)
Statistical analyses of clinical trials in haematopoietic cell transplantation or why there is a strong correlation between people drowning after falling out of a fishing boat and marriage rate in Kentucky (2019) (5)
Deoxycytidine Kinase (DCK) Mutations in Human Acute Myeloid Leukemia Resistant to Cytarabine (2021) (5)
Hematopoietic Recovery and Overall Survival after HLA-Matched Sibling Transplants for Older Patients with Severe Aplastic Anemia (SAA). (2008) (5)
Communicating cancer risk from radiation exposures: nuclear accidents, total body radiation and diagnostic procedures (2013) (5)
8 Intensive therapy of chronic lymphocytic leukaemia (1993) (5)
Maintenance tyrosine kinase inhibitors following allo-HCT for chronic myeloid leukemia: A CIBMTR Study. (2019) (5)
Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells. (1988) (5)
Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm (2021) (5)
HOW DOSE BONE MARROW TRANSPLANTION CURE LEUKEMIA (1984) (5)
Where does transformation occur in acute leukemia? (1991) (5)
BONE MARROW TRANSPLANTATION BETWEEN MIXED LYMPHOCYTE CULTURE‐REACTIVE INDIVIDUALS (1975) (5)
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improves Transplant Outcomes in Older MDS Patients. (2021) (5)
Clinical transformation of chronic lymphocytic leukemia. (1988) (5)
Are myelodysplastic syndromes and acute myeloid leukemia one disease? (2009) (5)
MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WHO RELAPSE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR LYMPHOMA: A REPORT OF THE INTERNATIONAL BONE MARROW TRANSPLANT REGISTRY Running head: Allogeneic transplants after autologous failure For Submission to BLOOD, Trans (2004) (5)
A SAS macro for estimating direct adjusted survival functions for time-to-event data with or without left truncation (2021) (5)
Cellular immunotherapy of cancer : proceedings of the International Symposium on Cellular Immunotherapy of Cancer, held at Racine, Wisconsin, October 30-November 1, 1986 (1987) (5)
Who Has Therapy-Related AML? (2017) (5)
Radiation: What It Is, What You Need to Know (2013) (5)
Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy (1997) (5)
EVALUATION OF ANTITHYMOCYTE GLOBULIN FOR HUMAN BONE MARROW TRANSPLANTATION: ANTIHEMATOPOIETIC AND IMMUNOSUPPRESSIVE ACTIVITY (1982) (5)
Bone marrow modulaton of spontaneous killer cellular cytotoxicity (SKCC) induction. (1980) (5)
Oncogenes in human leukemias. (1988) (5)
How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic? (2021) (5)
Chronic myelogenous leukaemia: a model for human cancers. (1987) (5)
Improving survival in acute myeloid leukemia: pick the best subjects? (2013) (5)
Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms‐like tyrosine kinase 3 internal tandem duplication (FLT3‐ITD) (2020) (5)
MNSs antigens and graft versus host disease following bone marrow transplantation. (1980) (5)
Hematopoietic growth factors in bone marrow transplantation: current and future directions. (1991) (5)
Methods for assessment of graft-versus-host disease [5] (multiple letters) (1998) (5)
AMSA: a phase II trial in resistant and recurrent acute myelogenous leukemia. (1984) (5)
The state of haematopoietic cells transplantation in Latin America. (2021) (4)
How Helpful Are Meta-Analyses in Determining the Best Therapy of Blood Diseases? (2010) (4)
Allogeneic hematopoietic cell transplants for thalassemia (2017) (4)
Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia? (2019) (4)
Chronic lymphocytic leukemia in 2020: a surfeit of riches? (2020) (4)
Therapy decisions in leukemia. (1992) (4)
RBC distribution width predicts thrombosis risk in polycythemia vera (2021) (4)
Intensive therapy of chronic lymphocytic leukaemia. (1993) (4)
E Donnall Thomas (1920–2012) (2012) (4)
USSR: follow-up after Chernobyl. (1990) (4)
[Use of a polyvalent intravenous immunoglobulin or specific cytomegalovirus hyperimmunoglobulin for modification of cytomegalovirus infections and prevention of interstitial pneumonias following bone marrow transplantation]. (1985) (4)
Is remission in acute myelogenous leukemia re-establishing preleukemia? (1990) (4)
Chronic myelogenous leukemia as a model of cancer development. (1995) (4)
Einsatz von polyvalentem intravenösem Immunglobulin oder spezifischem Zytomegaliehyperimmunglobulin zur Modifikation von Zytomegalievirusinfektionen und Prophylaxe von interstitiellen Pneumonien nach Knochenmarktransplantation. (1985) (4)
A cytoreductive conditioning program for bone marrow transplantation in resistant leukemia (SCARI). (1977) (4)
Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer (2003) (4)
Oncogenes in human leukemias. (1987) (4)
Colony-forming unit cell (CFU-C) assays at diagnosis: CFU-G/M cluster predicts overall survival in myelodysplastic syndrome patients independently of IPSS-R (2016) (4)
Can Long-Term Bone Marrow Culture Eliminate Leukemia Cells? (1990) (4)
Sensitization against non-HLA antigens following bone marrow graft rejection. (2008) (4)
Plasma cell leukemia with iga paraproteinemia and hyperviscosity (1988) (4)
Prognostic factors in acute myelogenous leukemia. (1987) (4)
Point: Is there a best duration of deep molecular response to achieve therapy‐free remission in chronic myeloid leukaemia? (2020) (4)
The future of research in hematology: Integration of conventional studies with real-world data and artificial intelligence. (2021) (4)
Are We Prepared for Nuclear Terrorism? (2018) (4)
Autotransplantations Without Cryopreservation (2018) (4)
Naltrexone sensitive suppression of the immune systems natural killer cells by morphine (1984) (4)
Impact of socio-demographic co-variates on prognosis, tyrosine kinase-inhibitor use and outcomes in persons with newly-diagnosed chronic myeloid leukaemia (2021) (4)
Myeloid colony-forming cell kinetics in man. (1980) (4)
[Stem cells, clonality and leukemia]. (1991) (4)
One or two umbilical cord blood cell units? Caveat emptor (2017) (4)
Second Malignancies After Autologous Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis (2012) (4)
Current status of allogeneic bone marrow transplantation: a report from the International Bone Marrow Transplant Registry. (1986) (4)
New study-designs to address the clinical complexity of acute myeloid leukemia (2019) (4)
Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera (2021) (4)
Bone marrow transplantation in patients with leukaemia previously transfused with blood products from family members (1987) (4)
Mutational features of myelodysplastic syndromes with Auer rods reveal them are more akin to acute myeloid leukemia (2019) (4)
Bone marrow fibrosis in myeloproliferative neoplasms-associated myelofibrosis: deconstructing a myth? (2011) (4)
Can intensive chemotherapy cure chronic myelogenous leukemia? (1992) (4)
Therapy of acute leukemia: highlights of the Fifth International Symposium on Therapy of Acute Leukemia, held in Roma on 1-6 November, 1991. (1992) (4)
Bone marrow transplantation in leukemia. (1994) (4)
Prevention and Treatment of Infections After Bone Marrow Transplantation (1988) (3)
Will immune therapy cure acute myeloid leukemia? (2019) (3)
Clinical Relevance of VEGFA (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes (2021) (3)
Current status of bone marrow transplantation in acute leukemia. (1979) (3)
Clinical trials of bone marrow transplantation. (1986) (3)
Can a disease be conquered by extensive publications, reading guidelines and interminable meetings? (2020) (3)
Impact of Pre-transplant Therapy and Depth of Disease Response prior to Autologous Transplantation for Multiple Myeloma (2015) (3)
Successful engraftment of cryopreserved autologous bone marrow stem cells in man. (1979) (3)
The role of bone marrow transplantation in acute myelogenous leukemia. (1987) (3)
Immunologic approaches to the classification of lymphomas and lymphoid leukemias. (1988) (3)
Intravenous immunoglobulin given to lymphoma patients with recurrent haemolytic transfusion reactions after transfusion of compatible blood (2005) (3)
Fetal liver cell transplantation in dogs: results with DLA-compatible and incompatible grafts. (1985) (3)
Does a durian smell like a rose? The dangers of jargon (2019) (3)
New cancer therapies. Are haematopoietic cell transplants a dead duck? (2020) (3)
Risk-Factors for Acute Graft-Versus-Host Disease and Survival After Hematopoietic Cell Transplantation From Siblings and Unrelated Donors – An Analysis of the CIBMTR (2010) (3)
Granulocyte transfusions in haematopoietic cell transplants and leukaemia: the phoenix or beating a dead horse? (2021) (3)
Transplantation of T lymphocyte depleted bone marrow to prevent graft-versus-host disease: its implications for fetal liver transplantation. (1985) (3)
COMPARISON OF GRAFT-VS-HOST-DISEASE AND SURVIVAL AFTER HLA- IDENTICAL SIBLING BONE MARROW TRANSPLANTATION IN DIFFERENT ETHNIC POPULATIONS Running Head: Graft-vs-host disease in ethnic populations For Submission to BLOOD, Clinical Observations (2004) (3)
Autologous bone marrow transplantation in patients with cancer. (1981) (3)
Hypothesis: additional cytogenetic abnormalities and progression to acute phase in chronic myelogenous leukemia. (1991) (3)
New strategies in bone marrow transplantation : proceedings of a Sandoz-UCLA Symposium held in Keystone, Colorado, January 20-27, 1990 (1991) (3)
Workshop : high dose etoposide containing regimens (1995) (3)
A prognostic immune risk score for diffuse large B‐cell lymphoma (2021) (3)
Emil J Freireich and Baruch Spinoza: birds of a feather? (2021) (3)
A phase 2, multicenter, open-label study of the safety and efficacy of luspatercept in subjects with myeloproliferative neoplasm (MPN)-associated myelofibrosis and anemia with or without RBC transfusion dependence. (2018) (3)
The prognostic role of HBV infection in chronic lymphocytic leukemia (2018) (3)
The paradox of haematopoietic cell transplant in Latin America (2021) (3)
Hepatitis b virus inhibition of myeloid stem cells (1984) (3)
STAT3 and STAT5B mutations have unique distribution in T-cell large granular lymphocyte proliferations and advanced myeloid neoplasms (2021) (3)
Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma (2020) (3)
Transplants in AML. (1992) (3)
Controversies in therapy of acute lymphoblastic leukemia. (1992) (3)
Comparison of Total Body Irradiation-Based with Intravenous Busulfan-Based Chemotherapy-Only Conditioning Regimens for Myeloablative Hematopoietic Cell Transplantation (HCT) in Adults with Acute Lymphoblastic Leukemia (2016) (3)
Phase-II trial of fractionated total body radiation in bone marrow transplantation for acute leukemia. [X radiation] (1979) (3)
Primary myelofibrosis: rs2010963 VEGFA polymorphism favors a prefibrotic phenotype and is associated with higher risk of thrombosis. (2021) (3)
Dirk Willem van Bekkum: a pioneer in haematology, transplantation and radiobiology (1925–2015) (2015) (3)
Correlations between Mutations in Cancer-Related Genes, Therapy Responses and Outcomes of the 3 rd Generation Tyrosine Kinase-Inhibitor (TKI) in Persons with Chronic Myeloid Leukemia Failing Prior TKI-Therapy (2021) (3)
Immunologic and clinical perspectives in human bone marrow transplantation. (1978) (3)
Pomalidomide (POM) In Advanced Corticosteroid-Resistant Chronic Graft-Versus-Host Disease (cGVHD) (2010) (3)
Are we curing acute myelogenous leukemia? (1993) (3)
Detection of non-HLA antigens: effect of lymphocyte priming and amplification signals. (1979) (3)
Improving prediction accuracy in acute myeloid leukaemia: micro-environment, immune and metabolic models (2021) (3)
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML (2021) (3)
A Critical Reappraisal of Gastrointestinal Complications of Allogeneic Bone Marrow Transplantation (1992) (3)
Transmission of CML or of t(9; 22) and BCR/ABL? They are not the same (2015) (3)
PF-114 in Patients Failing Prior Tyrosine Kinase-Inhibitor Therapy Including BCR::ABL1T315I (2021) (3)
Response to Vriesendorp et al. (1991) (3)
Analysis of treatment response in chronic lymphocytic leukemia: new approaches. (1988) (3)
Chronic Graft-Versus-Host Disease Risk Score: A CIBMTR Analysis (2010) (3)
What is the best strategy for autotransplants in cancer? (1992) (2)
Recent advances in leukemia and lymphoma : proceedings of a Schering Corporation-UCLA Symposium held in Keystone, Colorado, January 25-31, 1987 (1987) (2)
Toward the Cure of Acute Lymphoblastic Leukemia in Children in China (2021) (2)
Therapeutic complications in acute myelogenous leukemia. (1979) (2)
APLASTIC ANAEMIA TREATED WITH ANABOLIC STEROIDS (1979) (2)
Interstitial Pneumonitis After Bone Marrow Transplantation (2020) (2)
Economics influences therapy decisions in chronic myeloid leukaemia: should it? (2021) (2)
Fetal liver transplantation in man. (1985) (2)
Acute lymphoblastic leukemia: current controversies, future directions. (1989) (2)
Transplant indications, guidelines and recommendations: Caveat Emptor (2021) (2)
Bone marrow transplantation in aplastic anemia and leukemia. (1980) (2)
Fetal liver transplantation in hematologic disorders. (1985) (2)
LYMPHOID IMMATURITY AND T SUBPOPULATION IMBALANCES IN HUMAN DISEASE (1982) (2)
Phase-2 Study of Pomalidomide in Advanced Corticosteroid-Resistant Chronic Graft-Versus-Host Disease (cGVHD). (2009) (2)
Autotransplants in men with breast cancer. ABMTR Breast Cancer Working Committee. Autologous Blood and Marrow Transplant Registry. (1999) (2)
Cost-Effectiveness of Post-Autotransplant Lenalidomide in Persons with Multiple Myeloma (2021) (2)
Chemotherapy versus transplantation: II. Acute lymphoblastic leukemia. (1989) (2)
A critical reappraisal of gastrointestinal complications of allogeneic bone marrow transplantation. (1992) (2)
Reply to Passamonti et al: ruxolitinib and survival improvement in patients with myelofibrosis (2014) (2)
Human lymphocyte subpopulations: rosette formation with sheep, human and horse red blood cells. (1977) (2)
Hematopoietic Cell Transplants: Concepts, Controversies, and Future Directions (2017) (2)
Associations between gender , disease features and symptom burden in the MPN population : An analysis by the MPN QOL International Working Group (2016) (2)
Fallout from Chernobyl. Not all health problems seen close to Chernobyl can be attributed to radiation. (1994) (2)
Measurable residual disease testing in chronic lymphocytic leukaemia: hype, hope neither or both? (2021) (2)
Is there a reason to use blood cell transplants (1992) (2)
Therapy-Related AML and MDS: Who Really Has It? (2015) (2)
IVIG in Bone Marrow Transplantation (1997) (2)
Clinical models of autotransplants in chronic myelogenous leukemia. (1993) (2)
Impact of Disease Duration upon Symptom Burden Amongst Patients with Myeloproliferative Neoplasms (MPNs) (2015) (2)
Experience with incompatible maternal donors for bone marrow transplantation (2005) (2)
Is race important in genomic classification of hematological neoplasms? (2021) (2)
Bone-marrow transplantation for leukaemia (1995) (2)
A brief history of hematopoietic cell transplantation (2017) (2)
Analysing early liver dysfunction after bone marrow transplantation. (1993) (2)
EVALUATION OF ANTITHYMOCYTE GLOBULIN FOR HUMAN BONE MARROW TRANSPLANTATION III. EFFECT OF ANTITHYMOCYTE GLOBULIN TREATMENT ON T CELL PRECURSORS (1981) (2)
Prior Therapy with Rituximab Correlates with Less Acute Graft-Versus-Host Disease and Better Survival in B-Cell Lymphoma Patients Who Received Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT). (2007) (2)
‘Yet another rose’ (2013) (2)
Surgery and Chemotherapy versus Chemotherapy Only in Older Persons with Primary Intestinal Diffuse Large B-Cell Lymphoma (2021) (2)
Blood cell and bone marrow transplants. (1996) (2)
Conventional interferon-a 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center (2022) (2)
Is Iron-Chelation Therapy Useful in Persons with Myelodysplastic Syndrome Receive? (2011) (2)
Thirty years of Bone Marrow Transplantation (2016) (2)
Croatia: Civilian hospitals as military targets (1992) (2)
Age and Cost Are Associated with Patient Preference for Stopping Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia (2015) (2)
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis (2022) (2)
Isochromosome X in Myelodysplastic Syndrome (2015) (2)
IBMTR Analysis of Results of Bone Marrow Transplantation in Acute Leukemia (1994) (2)
Survival and immune recovery in dogs following fetal liver transplantation. (1987) (2)
EFFECT OF ANTITHYMOCYTE GLOBULIN ON HISTOCOMPATIBILITY ANTIGEN RECOGNITION IN MAN (1981) (2)
Will more intensive chemotherapy of leukemia increase cures? (1991) (2)
Chronic myeloid leukemia: Two mysteries. (2019) (2)
Definition of disease‐progression risk stratification in untreated chronic lymphocytic leukemia using combined clinical, molecular and virological variables (2017) (2)
Prophylactic use of immunoglobulin in bone marrow transplantation. (1986) (2)
Ibrutinib in Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Lower Risk of Hepatitis B Virus Reactivation (2021) (2)
Ph1‐chromosome positive acute lymphoblastic leukemia: Is t(9;22) the initial abnormality? (1993) (1)
A Haematologist's Guide to Coronavirus Disease 2019: Encyclopaedia or Doorstop? (2020) (1)
Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era (2021) (1)
Professor John M Goldman, 1938–2013: Gentleman and Scholar (2014) (1)
Daunorubicin or doxorubicin in acute myelogenous leukemia? (1988) (1)
[Aplastic anemia following acute viral hepatitis associated with hypogammaglobulinemia--attempted treatment by bone marrow transplantation]. (1975) (1)
Chernobyl: Answers Slipping Away (1990) (1)
33: Similar Graft-Versus-Leukemia Effect Using Matched Unrelated Donors, Compared to HLA-Identical Siblings for Hematopoietic Stem Cell Transplantation (2008) (1)
Modulation of Graft-versus-Host (GvH) Disease in the Rat; Effect of Hydroxyurea on the Mixed Lymphocyte Reaction and Graft-versus-Host Reactivity (1977) (1)
Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic leukemia (2022) (1)
A Rapid, Sensitive and Specific Method for Quantifying Calr Mutant Allele Burden in Persons with Myeloproliferative Neoplasms (2015) (1)
Chernobyl: the final warning (1988) (1)
New insights into a chronic lymphocytic leukemia. (1987) (1)
Alternative donor transplants for leukemia (1993) (1)
Blood-cell banking for workers at the Fukushima Daiichi nuclear power plant (2011) (1)
Hematopoietic cell transplants for T-cell lymphomas (2017) (1)
Progress in acute myelogenous leukemia. (1984) (1)
SP-006 ATOMIC BOMBS, RADIATION THERAPY AND CML. SOMETHING'S ROTTEN IN DENMARK (2014) (1)
Treating Plasma Cell Myeloma in Developing Countries: Does Everyone Need the Newest Drugs? (2020) (1)
Blood cell changes after radiation exposure. (1988) (1)
Are autotransplants effective in leukemia? (1992) (1)
Association of Chronic Graft-versus-Host Disease with Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy. (2022) (1)
Reduced-Intensity transplants, conventional transplants or chemotherapy for acute myeloid leukemia in 1st remission: who knows; ask your wife? (2015) (1)
Acute myelogenous leukemia : progress and controversies : proceedings of a Wyeth-Ayerst-UCLA Symposia Western Workshop held at Lake Lanier, Georgia, November 28-December 1, 1989 (1990) (1)
Bone Marrow Transplantation in Children and Adolescents with Leukemia (1991) (1)
Autotransplants for germ cell tumor: How best to do it (2017) (1)
E. Donnall Thomas (1920–2012): Bone Marrow Transplants Pioneer and Nobel Laureate (2013) (1)
Granulocyte transfusions. (1980) (1)
Dead/H-Box Helicase 11 (DDX11) Mutations Correlate with Increased Relapse Risk in Persons with Acute Myeloid Leukaemia and Promote Proliferation and Survival of Human AML Cells in Vitro and in Immune Deficient Mice (2019) (1)
Pomalidomide Therapy in Myelofibrosis: 2-Year Follow-up of a Randomized Phase 2 Study. (2009) (1)
BONE MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKAEMIA (1983) (1)
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis (2021) (1)
Response to the Commentary on “Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma” (2019) (1)
Impact of Chronic GVHD on Late Relapse, Treatment Related Mortality and Survival After Allogeneic Hematopoietic Cell Transplantation for Hematological Malignancies (2012) (1)
Xenophobia, T cells and a journey to a foreign land. (1990) (1)
Immune development in human fetal liver. (1985) (1)
Current issues in chronic lymphocytic leukemia. (1988) (1)
ORIGINAL ARTICLE Genetically identical twin transplantation for chronic lymphocytic leukemia (2007) (1)
Infection in bone-marrow recipients. (1979) (1)
VEGFA rs3025020 Polymorphism Contributes to CALR -Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis (2021) (1)
The impact of cult behavior on haematopoietic cell transplant practices: believers and non-believers (2021) (1)
Chronic lymphocytic leukemia in China (2021) (1)
Transplants for MDS and quality-of-life. But whose quality-of-life? (2016) (1)
Therapy for Immunoglobulin D Plasma Cell Myeloma (2018) (1)
What do cytogenetic abnormalities after autotransplant really mean? (2014) (1)
Response to “An Unexpected Mortality Increase in the United States Follows Arrival of the Radioactive Plume from Fukushima: Is There a Correlation?” (2012) (1)
Lymphoma Nomenclature ‐ What's in a name? (2022) (1)
Predicting results of alternative donor transplants for thalassemia using a chronic myelogenous leukemia model. (1993) (1)
The Role of Cyclophosphamide and Total-body Irradiation in Marrow Transplantation for Severe Aplastic Anemia (1978) (1)
Perspective: Cell therapy, SARS‐CoV‐2, COVID‐19, and James Lind (2020) (1)
Transplants for аcute myeloid leukaemia in 1st remission: statisticians, magicians and the rest of us (2017) (1)
A cluster of vitreoretinal lymphoma in New York with possible link to the Chernobyl nuclear disaster (2018) (1)
Professor John M. Goldman, CML Pioneer 1938–2013 (2014) (1)
Symptom Burden Profile in Myelofibrosis Patients with Thrombocytopenia: Lessons and Unmet Needs (2015) (1)
Is there a role for haematopoietic cell transplants after radiation and nuclear accidents? (2021) (1)
Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT (2019) (1)
Response to “Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions” by Heidel et al. (2018) (1)
Role of Hematopoietic Growth Factors in Radiation Victims (1990) (1)
Liaisons Dangereuses? new drugs, physicians and the drug industry (2020) (1)
4th International workshop on CLL (1989) (1)
The Russian invasion of Ukraine: Implications for haematologists (2022) (1)
Risk Factors for Major Transplant Related Outcomes In Pediatric Patients with Chronic Graft-Versus-Host Disease (2010) (1)
Immune therapy of chronic myelogenous leukemia. (2005) (1)
Final Results of a Randomized Phase 2 Trial Evaluating Lower-Dose Versus Higher-Dose Pomalidomide as Therapy for Corticosteroid-Refractory Chronic Gvhd (2016) (1)
Recent progress in understanding chronic myelogenous leukemia. (1993) (1)
Recent progress in B- and T-cell lymphomas. (1994) (1)
Comparison of Outcomes for Myeloablative Conditioning Regimens Combining Busulfan with Either Cyclophosphamide or Fludarabine in Children (2016) (1)
Correction of murine sickle cell disease by allogeneic haematopoietic cell transplantation with anti-3rd party veto cells (2021) (1)
Perspective: Chernobyl and leukemia. (1991) (1)
The not so new history of storing bone marrow (2019) (1)
Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre (2020) (1)
Improved? Bone Marrow Transplantation for Severe Aplastic Anemia: Has Outcome (2012) (1)
255 RESPONSE TO THALIDOMIDE AND CYCLOSPORINE IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROME WITHOUT ISOLATED DEL(5Q) (2015) (1)
Progress in bone marrow transplantation : proceedings of the Fourth International UCLA Symposium on Bone Marrow Transplantation, held in Keystone, Colorado, April 13-18, 1986, sponsored by Sandoz, Inc. (1987) (1)
Treatment strategies for acute lymphoblastic leukemia. (1990) (1)
Does more intensive therapy increase cures in acute leukemia? (1991) (1)
Acute leukaemias: biology and treatment. (1986) (1)
HGNC nomenclature for fusion genes (2021) (1)
Study Limitations in HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia. (2018) (1)
Effect of pediatric- versus adult-type chemotherapy regimens on outcomes of allogeneic hematopoietic stem cell transplants for adult T-cell acute lymphoblastic leukemia in first complete remission (2022) (1)
Chronic myelogenous leukemia: molecule to man. (1991) (1)
Corrigendum to "BCL11A expression in acute phase chronic myeloid leukemia" [Leuk. Res. 47 (2016) 88-92]. (2017) (1)
Bone marrow transplantation in acute leukemia: current status and future directions. (1979) (1)
Humoral stimulation of hemopoietic progenitors from human fetal liver. (1982) (1)
146: Use of a novel organic arsenic (ZIO-101) after autotransplants for multiple myeloma (2007) (1)
Hematopoietic cell transplants in resource-poor countries: challenges and opportunities (2023) (1)
Standardizing haematopoietic cell transplants in China (2018) (1)
Introducing Prof. Shaun McCann, Bone Marrow Transplantation’s New Sommelier (2018) (1)
CBeV (cyclophosphamide, bendamustine and etoposide) pre-autotransplant conditioning in persons with lymphoma (2019) (1)
Multiple Myeloma and Chronic Lymphocytic Leukemia: Commonalities and Differences in Biology and Therapy. (1991) (1)
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis. (2023) (1)
Outpatient Autotransplants for Persons with Multiple Sclerosis (2018) (1)
Fetal liver transplantation : proceedings of an international symposium held in Pesaro, Italy, September 29-October 1, 1984 (1985) (1)
Chronic graft-versus-host disease: Consensus, challenges, and controversies (2017) (1)
Hematopoietic cell transplantation: Is there any age limit? (2017) (1)
Survival Trends after Allogeneic Hematopoietic Cell Transplant (HCT) in Children Less Than One-Year-Old (Infants) (2018) (0)
Assessment of comorbidities for hematopoietic cell transplants: Achievements and controversies (2017) (0)
A Simple Prognostic System in Myelofibrosis Patients Undergoing Allogeneic Stem Cell Transplant: A CIBMTR/EBMT analysis. (2023) (0)
Hematopoietic cell transplants for bone marrow failure disorders (2017) (0)
Organ-specific complications after hematopoietic cell transplants: Practical considerations and controversies (2017) (0)
Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression) (2021) (0)
CRITICAL CARE ASPECTS OF STEM CELL TRANSPLANTATION (2017) (0)
Biology: Critical components of hematopoietic cell transplantation (2017) (0)
SURVIVAL AFTER RELAPSE IN ACUTE MYELOID LEUKÆMIA (1978) (0)
Controversies and challenges in HLA-haplotype-matched transplants for leukaemia (2019) (0)
Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies (2022) (0)
Isophosphoramide mustard-lysine (IPM-L; ZIO-201): A new alkylator for bone marrow transplants (2006) (0)
In memory of Professor Valery Savchenko. January 8, 1952 – July 25, 2021 (2021) (0)
Conditioning regimens: Do they really matter? (2017) (0)
Transplants for acute myelogenous leukemia. (1998) (0)
High sensitivity PCR testing for BCR/ABL1 mRNA transcripts in persons with CML. (2013) (0)
John Michael Goldman (1938-2013): Transplant Pioneer (2014) (0)
Infectious diseases: Evaluation and implications of results in hematopoietic cell transplants (2017) (0)
Geoffrey Peter Herzig, MD (1941–2013): Transplant Pioneer (2014) (0)
Valeriy Grigorievich Savchenko: pioneering Russian haematologist 8 January 1952–25 July 2021 (2021) (0)
E11 Predicated health consequences of the Chernobyl nuclear power station accident 1986–2065 (2007) (0)
Roger Herschel Herzig: younger half of the dynamic duo which advanced leukaemia therapy and transplants: January 4, 1946 to July 18, 2020 (2020) (0)
Johannes Joseph van Rood: pioneer in immuno-genetics (7 April 1926–21 July 2017) (2017) (0)
Chronic lymphocytic leukemia : recent progress and future direction : proceedings of a Hyland Laboratories-UCLA symposium held in Napa, California, December 2-5, 1986 (1987) (0)
Statistical challenges in haematopoietic cell transplantation (2022) (0)
Hematopoietic cell transplants for indolent lymphomas (2017) (0)
Concepts underlying autotransplants for cancer. (1995) (0)
In Memoriam: Paul I. Terasaki-September 10, 1929 to January 25, 2016. (2016) (0)
Autotransplants f or H odgkin's D isease i n P atients N ever Achieving R emission: A R eport F rom t he A utologous B lood and M arrow T ransplant R egistry (2011) (0)
Prof. Theodor M. Fliedner (1 October 1929–9 November 2015): haematopoietic stem cell and radiation biology and pioneer (2016) (0)
Autotransplant Activity 1989–1994 (2020) (0)
Contents Vol. 129, 2013 (2013) (0)
WHAT IS THE BEST STRATEGY FOR AUTOTRANPLANTS IN CANCER (1992) (0)
Cell therapy of chronic lymphocytic leukaemia: Transplants and chimeric antigen receptor (CAR)-T cells. (2021) (0)
Comparison of the Myleloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) Across Nine Linguistic Translations Among an International Sample of 1,851 Myeloproliferative Neoplasm (MPN) Patients. (2012) (0)
The Frontiers of Plasma Cell Neoplasms JiFeng Yu and Peter Y. Z. Jiang (editors) Amazon.com direct publishing, USA, 2021 (ISBN: 9798589451924). (2022) (0)
Are there really cancer stem cells and how do they operate? (2020) (0)
The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort (2013) (0)
John Leslie Fahey 1924–2014 (2014) (0)
Hematopoietic cell transplants for central nervous system lymphomas (2017) (0)
Are we really doing hematopoietic stem cell transplantations? (2013) (0)
Chronic lymphoproliferative disorders. (1994) (0)
Will new drugs cure acute myeloid leukaemia? (2022) (0)
Hematopoietic cell transplants for acute myeloid leukemia: Is there a best approach? (2017) (0)
Donor lymphocyte infusion: Rationale, benefits, and limitations (2017) (0)
Oncogenes in Acute Myelogenous Leukemia (1988) (0)
Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia (2016) (0)
Professor Shigetaka Asano: extraordinary Japanese haematologist and bon vivant February 7, 1943 to August 12, 2020 (2020) (0)
Intensive therapy and hematopoietic stem cell rescue in lymphoma : summary of the Keystone Lymphoma Workshop (1995) (0)
The Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Transplantation (2017) (0)
Sarcophagus : a tragedy (1987) (0)
CMV Infection and its Prevention with Specific Immunoglobulins (1984) (0)
Impact of Higher-Dose Total Body Irradiation Conditioning on Outcome of an Allogeneic Hematopoietic Cell Transplant (HCT) in the Modern Era (2017) (0)
Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation (2018) (0)
Chinese and Europeans with Acute Myeloid Leukemia Have Different Topologies of Mutations (2017) (0)
Autotransplants for Lymphoid Neoplasms Increase the Risks of MDS More Than AML (2017) (0)
Spontaneous uptake of 3H-thymidine by lymphocytes of bone marrow transplanted recipients. (1977) (0)
Marrow Transplant Registry and the National Marrow Donor Program Wiskott-Aldrich syndrome: collaborative study of the International Bone Impact of donor type on outcome of bone marrow transplantation for (2012) (0)
Progress treating acute graft-versus-host disease? (2017) (0)
Hematopoietic growth factors after hematopoietic cell transplantation: Are they useful? (2017) (0)
Advances in Brief Cloning of the ALL . 1 Fusion Partner , the AF-6 Gene , Involved in Acute Myeloid Leukemias with the t ( 6 ; ll ) Chromosome (2007) (0)
Professor Shigetaka Asano: extraordinary Japanese Haematologist and Bon Vivant February 7, 1943 to August 12, 2020 (2020) (0)
David C Seldin, MD, PhD: scientist, clinician, teacher, gentleman, 1957–2015 (2016) (0)
Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants? (2009) (0)
Strategies to augment graft-versus-leukemia and -lymphoma effects (2017) (0)
Allogeneic hematopoietic cell transplants for plasma cell myeloma (2017) (0)
Isophosphoramide mustard-lysine (ZIO-201): A potential new alkylator for bone marrow transplants (2006) (0)
Association between the Philadelphia chromosome and a unique abl transcript. (1985) (0)
Adoptive cell therapy for cancer using T-cells genetically engineered to express chimeric antigen receptors (2017) (0)
Minimal Residual Disease in Leukemia: 1986 (1986) (0)
Autotransplants for neuroblastoma (2017) (0)
Allogeneic hematopoietic cell transplants for BCR/ABL negative myeloproliferative neoplasms (2017) (0)
Prevention and treatment of bacterial infections in hematopoietic cell transplants (2017) (0)
Genomic Landscape and Risk-Stratification for De Novo Acute Myeloid Leukemia with Normal Cytogenetics and No NPM1 or FLT3-itd Mutation (2019) (0)
Lower Transplant-Related Mortality and Improved Survival for Patients with AML in First CR Receiving BuCy Compared to Cy/TBI As Myeloablative Preparation for Allogeneic Transplantation: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR) (2012) (0)
Expanded umbilical cord cells: Benefits and limitations (2017) (0)
Hematopoietic cell transplantation for immunoglobulin light chain (AL) amyloidosis (2017) (0)
Can Immune Therapy Cure Acute Myeloid Leukemia? (2020) (0)
Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era (2021) (0)
Prevention of acute graft-versus-host disease – one size fits all? (2017) (0)
An 8-kilobase abi RNA transcript in chronic myelogenous leukemia ( granulocytes / cancer / translocation / oncogene activation / Philadelphia chromosome ) (1999) (0)
Blood group incompatibilities and transfusion support after hematopoietic cell transplant (2017) (0)
Therapy of older persons with acute myeloid leukemia (2015) (0)
Minimal residual disease in acute leukemias: Are we on the right path? (2017) (0)
CLL with a CD200-negative, FMC7-positive immune phenotype is associated with del(17p) and complex cytogenetic abnormalities (2017) (0)
Leukemia : recent advances in biology and treatment : proceedings of a UCLA Symposium held in Keystone, Colorado, January 27-February 2, 1985 (1985) (0)
Paul I Terasaki (10 September, 1929–25 January, 2016) (2016) (0)
Boris Afanasyev: The alphabet man of Russian hematopoietic cell transplantation (August 28, 1947 to March 16, 2020) (2020) (0)
Prof. Anton Hagenbeek 1948–2021: Father of MRD and Lymphoma Expert (2021) (0)
Impact of Chronic Graft-Versus-Host Disease on First Late Effect Among Adult Survivors of Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis (2021) (0)
The Clinical Significance and Biological Function of DPEP1 in B-cell Acute Lymphoblastic Leukemia (2019) (0)
New perspectives in manufacturing hematopoietic cells (2017) (0)
The BMT Data Book including Cellular Therapy, 3rd edition (2014) (0)
258 MUTATIONAL SPECTRUM AND PROGNOSTIC VALUE OF GENE MUTATIONS IN CHRONIC MYELOMONOCYTIC LEUKEMIA PATIENTS (2015) (0)
A Predictive Score for Failure-Free Survival in Persons with Chronic Myeloid Leukemia Receiving Imatinib (2021) (0)
Osteoclast Stimulatory Transmembrane Protein (OCSTAMP) mRNA Levels and Clinical Variables in Persons with Plasma Cell Myeloma (2018) (0)
Post-transplant relapse and graft failure: Does a second allogeneic hematopoietic cell transplant work? (2017) (0)
Edward Shelton Henderson MD Chemotherapy Pioneer July 19, 1932 to June 24, 2020 (2020) (0)
Zanubrutinib in Chronic Lymphocytic Leukemia. (2023) (0)
Professor John M. Goldman CML Pioneer and Journal Founder 1938–2013 (2014) (0)
Risks of New Myeloid Neoplasms after Autologous Transplant for Plasma Cell Myeloma and Lymphomas: Effects of Drug and Ionizing Radiation Exposures (2017) (0)
Strategies for acute myelogenous leukemia. (1991) (0)
Hematopoietic cell transplants for chronic lymphocytic leukemia: Changing landscape? (2017) (0)
Gene therapy in hematopoietic cell transplants (2017) (0)
Everyone is entitled to his or her own opinion but not to their own facts * (2022) (0)
Unrelated donor selection: Human leukocyte antigen testing and matching _ permissive and non-permissive matches (2017) (0)
Hematopoietic cell transplants for Hodgkin lymphoma (2017) (0)
CD34+ cell selection: Current concepts, methods, and controversies (2017) (0)
Is there a Future for Haematopoietic Cell Transplants? (2020) (0)
lymphoblastic leukemia in first complete remission Unrelated donor transplants in adults with Philadelphia-negative acute (2011) (0)
Bone marrow transplantation. (1991) (0)
Clonal Trajectories in Persons with Acute Myeloid Leukemia and Normal Cytogenetics Relapsing after Intensive Chemotherapy and after Allotransplants. Does Pretransplant Conditioning Contribute to Mutation Topography? (2018) (0)
Is there consensus on consensus? (2016) (0)
Leukemia 1985. Abstracts (1985) (0)
USSR: Follow-up after Cherriobyl (1990) (0)
Paul Ichiro Terasaki September 10, 1929 to January 25, 2016: Transplant Pioneer. (2016) (0)
Statistics: Do we understand the results of our analyses? (2017) (0)
Chronic Lymphocytic Leukemia (2020) (0)
Colony-Forming Unit Cell (CFU-C) Assays in Myelodysplastic Syndrome (2015) (0)
Results of Allogeneic Hematopoietic Cell Transplantation in Persons with Fanconi Anemia and Pretransplant Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia (2011) (0)
Spliceosome Mutations Are Common in MPN-Associated Myelofibrosis with RBC-Transfusion-Dependence and Correlate with Response to Pomalidomide (2018) (0)
Human leukocyte antigen-haplotype mismatch transplants: Overcoming major genetic barriers (2017) (0)
Hematopoietic cell transplants for aggressive B-cell lymphomas (2017) (0)
A prognostic survival nomogram for persons with extra-nodal natural killer-/T-cell lymphoma (2022) (0)
Bone marrow transplantation in leukemia. (1981) (0)
Cure of leukemia of bone marrow transplantation (1993) (0)
Workshop on immune reconstitution after BMT (1995) (0)
Johannes Joseph van Rood Pioneer in immuno-genetics (7 April 1926–21 July 2017) (2017) (0)
BONE MARROW TRANSPLANTATION: EXPERIMENTAL AND CLINICAL ASPECTS (1982) (0)
Roger Herschel Herzig: younger half of the dynamic duo which advanced leukaemia therapy and transplants: January 4, 1946 to July 18, 2020 (2020) (0)
CD34+ cell mobilization in autologous and allogeneic hematopoietic cell transplants (2017) (0)
Johannes Joseph van Rood: An Immunohematology Pioneer (1926-2017) (2017) (0)
Pharmacologic controversies in hematopoietic cell transplants (2017) (0)
Risk Factors and Outcome after Second HLA-Matched Sibling Donor Transplantation for Graft Failure after a First HLA-Matched Sibling Transplant in Severe Aplastic Anemia. (2007) (0)
Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase. (2023) (0)
Prof. Franco Mandelli Leukaemia Visionary. May 12, 1931– July 15, 2018 (2019) (0)
Monitoring Therapy-Response in acute myeloid leukemia (2016) (0)
Edward Shelton Henderson MD Chemotherapy Pioneer July 19, 1932 to June 24, 2020 (2021) (0)
High-dose chemo-radiotherapy with autologous bone marrow transplantation (ABMT) in patients with cancer (1981) (0)
Will New Drugs Replace Transplants for Chronic Lymphocytic Leukaemia? (2021) (0)
High Dose Chemotherapy With Blood or Marrow Transplant for Rhabdomyosarcoma: A CIBMTR Analysis (2009) (0)
Epstein_Barr virus-driven lymphoproliferation: Surveillance and therapy (2017) (0)
RISK FACTORS AFFECTING OUTCOME OF SECOND HLA-MATCHED SIBLING DONOR TRANSPLANTS FOR GRAFT FAILURE IN SEVERE ACQUIRED APLASTIC ANEMIA (2009) (0)
Short-term medical consequences of the chernobyl nuclear accident: lessons for the future. (1988) (0)
Thalassaemia in China. (2023) (0)
Regenerative medicine: The future? (2017) (0)
Hematopoietic cell transplants for myelodysplastic syndromes (2017) (0)
Co-Morbidity Profile Influences Work, Daily Life and Health-Related Quality-of-Life in Persons with Chronic Myeloid Leukemia Receiving Tyrosine Kinase-Inhibitor Therapy (2016) (0)
Bone marrow transplantation. (1985) (0)
Present status on bone marrow transplantation in U. S. A. (1982) (0)
EHT , a New Member of the MTG 8 / ETO Gene Family , Maps on 20 q 11 Region and Is Deleted in Acute Myeloid Leukemias (0)
What causes aplastic anaemia? (2023) (0)
Johannes Joseph van Rood, Transplantation Pioneer (April 7, 1926, to July 21, 2017). (2017) (0)
Autologous stem cell transplantation in multiple myelomy patients /-60 years of age (2003) (0)
Oncogenes in Chronic Myelogenous Leukemia (1986) (0)
Bone marrow transplantation in children (1982) (0)
Radiation and leukaemia: Which leukaemias and what doses? (2022) (0)
Symptomatic profiles of 1334 polycythemia vera patients: implications of inadequately controlled disease (2016) (0)
Survival and Late Effects of Children Undergoing Myeloablative Allogeneic HCT at Less Than Three Years of Age: A Report from the Center for International Blood and Marrow Transplant Research (2016) (0)
Autologous hematopoietic cell transplants for autoimmune diseases: Therapeutic rationale and limitations (2017) (0)
Curing leukemia. (1991) (0)
Geoffrey Peter Herzig, MD Leukemia Pioneer (1941–2013) (2014) (0)
Use Of The Functional Assessment Of Cancer Therapy-Anemia (Fact-An) Instrument In Persons With Mpn-Associated Myelofibrosis And Anemia (2012) (0)
Immune therapy with cytotoxic T-lymphocytes for treatment of infections (2017) (0)
First Late Effect in Pediatric Survivors with Chronic Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation for Hematologic Malignancy (2021) (0)
Cord blood cell transplants: Donor selection, volume, and controversies (2017) (0)
Prospects for correction of thalassemia by genetic engineering. (1989) (0)
Hematopoietic cell transplants in Jordan: different indications from the US and EU (2019) (0)
Leukemia: Recent advances in biology and treatment (1985) (0)
High-dose chemotherapy and autotransplants for plasma cell myeloma in Jordan (2018) (0)
Immune paralysis and reconstitution after hematopoietic cell transplants (2017) (0)
Outcomes of HLA Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative vs. Reduced-Intensity Conditioning Regimens (2014) (0)
Emergency response to nuclear and radiation accidents. (1989) (0)
KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition. (2023) (0)
John Hansen, MD (2019) (0)
Abstract 259: A case series of vitreoretinal lymphoma in New York City with exposure to Chernobyl nuclear disaster decades earlier (2017) (0)
Unmet Needs for Symptom Control in Essential Thrombocythemia with Front Line Therapy (2015) (0)
Ecclesiastes Strikes Again! (2015) (0)
Autologous hematopoietic cell transplants for plasma cell myeloma: One, two, or none? (2017) (0)
Proceedings of the Fifth Biennial Sandoz-Keystone Symposium on BMT : advances and controversies in bone marrow transplantation : January 23-28, 1994, Keystone, Colorado, USA (1995) (0)
T-cell depletion in allogeneic hematopoietic cell transplantation: Results, barriers, and future directions (2017) (0)
Prognostic Impact of Splenomegaly on Survival of Chinese with Primary Myelofibrosis (2014) (0)
Maintenance of human haematopoietic stem and progenitor cells in vitro using a chemical cocktail (2018) (0)
Elihu H. Estey, MD: leukemia expert, statistician, and gentle soul (July 15, 1946–October 8, 2021) (2021) (0)
Antitumor activity of some amino acid metal systems. (1977) (0)
Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectives (2023) (0)
Clara Bloomfield MD: Queen of AML. Dare to cross her at your risk (May 15, 1942 to March 1, 2020) (2020) (0)
Acute lymphoblastic leukemia : proceedings of a Wyeth-Ayerst-UCLA Western Workshop on Acute Lymphoblastic Leukemia, held at Tapatio Springs, Texas, November 29-December 2, 1988 (1990) (0)
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children (<18y) and Young adults (18–29y) with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis (2016) (0)
Bone marrow transplantation : current controversies : proceedings of a Sandoz-UCLA Symposium, held at Tamarron, Colorado, March 6-12, 1988 (1989) (0)
Glucose partitioning in the bone marrow micro-environment in acute myeloid leukaemia. (2023) (0)
Bone marrow transplantation for chronic myelogenous leukemia (CML) in chronic phase (1982) (0)
Validation of the imatinib-therapy failure model. (2023) (0)
Dissectioning Risk Factors for Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) after Autotransplants for Plasma Cell Myeloma and Lymphomas (2017) (0)
Bone-marrow transplantation in acute leukaemia. (1977) (0)
Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients. (2023) (0)
Valeriy Grigorievich Savchenko: pioneering Russian hematologist: 8 January 1952–25 July 2021 (2021) (0)
hematopoietic stem cell transplantation Impact of posttransplantation G-CSF on outcomes of allogeneic (2011) (0)
syndrome and acute myeloid leukemia Allogeneic transplantation for therapy-related myelodysplastic (2011) (0)
Cancer treatment in the blood bank: a growth industry? (1995) (0)
Preventing relapse post-transplant: When and how to best intervene? (2017) (0)
The Graft-Versus-Myeloma Effect Using Non-Myeloablative Or Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (2010) (0)
Communicating radiation-related cancer-risk to the public (2012) (0)
Theodor M Fliedner (1 October 1929–9 November 2015), transplant pioneer (2016) (0)
Patients9 and Physicians9 Concerns about Tyrosine Kinase-Inhibitor Therapy in Chronic Myeloid Leukemia (2016) (0)
Autologous hematopoietic cell transplants for autoimmune diseases: Specific diseases and controversies (2017) (0)
Prognostic mutations in persons with isolated neutropenia myelodysplastic syndrome (2019) (0)
Alternative donor transplants for leukemia. Scientific Advisory Committee of the International Bone Marrow Transplant Registry. (1993) (0)
Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response (2018) (0)
Immune Therapy of Human Cancers (1992) (0)
Biology of bone marrow transplantation : proceedings of the 1980 ICN-UCLA Symposia on Biology of Bone Marrow Transplantation held in Keystone, Colorado, February 17-21, 1980 (1980) (0)
COMPARABLE OUTCOMES IN NON-SECRETORY AND SECRETORY MULTIPLE MYELOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION (2009) (0)
A brief history of bone marrow transplantation (2018) (0)
Time to Reconsider Haematopoietic Cell Transplants in Chronic Myeloid Leukaemia? (2022) (0)
Hematopoietic cell transplants for chronic myeloid leukemia: Still a role for allogeneic transplant? (2017) (0)
Treatment of aplastic anemia. (1985) (0)
transplantation Risk factors for acute GVHD and survival after hematopoietic cell (2012) (0)
Statistics and the Great Persky. (2016) (0)
Corrigendum: Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia (2017) (0)
Clara Bloomfield MD: Queen of AML. Dare to cross her at your risk (May 15, 1942 to March 1, 2020) (2020) (0)
Prof. Thomas Büchner (22 September 1934-5 August 2016). A career devoted to research in acute myeloid leukaemia. (2016) (0)
with TBI following cyclophosphamide in combination with busulfan compared Better leukemia-free and overall survival in AML in first remission (2013) (0)
[Clinical use of hematopoietic growth factors (hematopoietins)]. (1993) (0)
Elihu H. Estey, MD: Leukaemia expert, statistician, and gentle soul (July 15, 1946–October 8, 2021) (2021) (0)
DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10–FGFR2 signaling (2022) (0)
Symptom Burden Characteristics Among Chinese Patients with Myeloproliferative Neoplasms (MPNs) (2012) (0)
Hematopoietic cell transplants for BCR/ABL negative acute lymphocytic leukemia (2017) (0)
Rolf Neth (October 6, 1926 to March 17, 2020) (2020) (0)
Maintenance therapy in plasma cell myeloma after autologous transplant (2017) (0)
Interferon Therapy of Chronic Lymphocytic Leukemia and Viral Infections in Leukemia Patients (1988) (0)
Hematopoietic cell transplants for Fanconi anemia (2017) (0)
Human circulating small non-coding RNA signature as a non-invasive biomarker in clinical diagnosis of acute myeloid leukaemia (2023) (0)
256 A STUDY OF CHARACTERISTICS OF COLONY-FORMING CELLS IN VITRO IN 560 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (2015) (0)
Armenia MEDICAL RELIEF AFTER THE EARTHQUAKE (1989) (0)
Essential Thrombocythemia (ET) and Polycythemia Vera (PV) Symptom Burden: Phenotypic Cluster Analysis Among an International Sample of 1,141 ET and PV Patients (2012) (0)
Estimating Therapy-Related Myeloid Neoplasm Risks in the US (2014) (0)
A Novel Erythroid Regulator MLF1IP Promotes Proliferation in Mice By Regulating Cell Cycle (2015) (0)
Selecting human leukocyte antigen haplotype mismatch versus cord blood graft (2017) (0)
Transplants for аcute myeloid leukaemia in 1st remission: standard of care or something else? (2018) (0)
Hematopoietic cell transplants for human immunodeficiency virus-related lymphomas (2017) (0)
Hematopoietic cell transplants for mantle cell lymphoma (2017) (0)
Professor Anton Hagenbeek 1948–2021: Father of MRD and lymphoma expert (2021) (0)
Molecular Aberrations of Chronic Neutrophilic Leukemia: The CSF3R and SETBP1 Mutations (2014) (0)
Quality of life: Can we really make a difference? (2017) (0)
Biologic Features of Chronic Lymphocytic Leukemia. (1991) (0)
Matched Related Donor Transplants for Sickle Cell Disease: Report from the Center for International Blood and Transplant Research. (2005) (0)
Emil J Freireich and Baruch Spinoza: birds of a feather? (2021) (0)
784 BONE MARROW TRANSPLANTATION (BMT) IN CHILDREN (1981) (0)
Commentary: How do haematopoietic cell transplants cure leukaemia? (2016) (0)
Allogeneic hematopoietic cell transplants for sickle cell disease (2017) (0)
Prof. Franco Mandelli: Leukaemia therapy pioneer (2018) (0)
Professor Theodor Fliedner and the Atomic Hematologists (2016) (0)
Why do subjects on clinical trials discontinue therapy? Do we really know? (2016) (0)
Improved Mortality Prognostication for Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results From a Virtual Pediatric Systems (VPS) and Center for International Blood and Marrow Transplant Research (CIBMTR) Database Merger (2018) (0)
NK cells for cancers (2017) (0)
High Incidences of Acute and Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplants for Acute Myeloid Leukemia Using Thiotepa, Busulfan, and Fludarabine Pretransplant Conditioning (2022) (0)
Academician Andrey Ivanovich Vorobiev, 1 November 1928 to 15 June 2020: founder of modern Soviet/Russian haematology (2020) (0)
Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation (2021) (0)
How can we know if new drugs are effective in myeloproliferative neoplasm-associated myelofibrosis? (2016) (0)
MNSs Antigens Graft versus Host Disease Following Bone Marrow Transplantation (2008) (0)
Sex differences in the incidence of chronic myeloid leukemia (2013) (0)
Allogeneic Hematopoietic Cell Transplantation (HCT) for Neuroblastoma (NB): The CIBMTR Experience (2011) (0)
Graft-Versus-Leukemia Effect Is Equivalent in Recipients of Matched Sibling and Matched Unrelated Donor Conventional Hematopoietic Cell Transplant. (2007) (0)
John M. Goldman, DM (1938-2013) (2014) (0)
Bone Marrow Transplantation Following Nuclear Accidents (1988) (0)
T-cell depletion in bone marrow transplantation (1989) (0)
Hematopoietic cell transplants for children with acute lymphoblastic leukemia (2017) (0)
Autotransplants in Advanced Non-Hodgkin Lymphoma: Are They Effective? (1992) (0)
Donor-specific anti-human leukocyte antigen antibodies and risk of graft failure after hematopoietic cell transplants (2017) (0)
Recent advances in bone marrow transplantation : proceedings of the UCLA Symposia Conference, held in Park City, Utah, March 13-18, 1983 (1983) (0)
Mesenchymal stromal cells and leukemia therapy in mice and man (2020) (0)
A Predictive Score for Outcomes of Tyrosine Kinase-Inhibitor Therapy in Persons with Chronic Myeloid Leukaemia Presenting in Accelerated Phase (2021) (0)
Comparison o f P reparative R egimens i n T ransplants f or Children W ith A cute L ymphoblastic L eukemia (2000) (0)
USA: New victims of the nuclear arms race (1990) (0)

This paper list is powered by the following services:

Other Resources About Robert Peter Gale

en.wikipedia.org

What Schools Are Affiliated With Robert Peter Gale?

Robert Peter Gale is affiliated with the following schools:

Robert Peter Gale's Academic­Influence.com Rankings

Why Is Robert Peter Gale Influential?

Robert Peter Gale's Published Works

Published Works

Other Resources About Robert Peter Gale

What Schools Are Affiliated With Robert Peter Gale?

Robert Peter Gale's AcademicInfluence.com Rankings